社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
函盖乾坤截断众流随波逐浪
内求,无漏
IP属地:河北
+关注
帖子 · 877
帖子 · 877
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
函盖乾坤截断众流随波逐浪
函盖乾坤截断众流随波逐浪
·
06-10
恒科成了垃圾桶
“大模型第一股”熄火?智谱股价自高点腰斩!纳入恒生科技指数两日市值再蒸发超20%
值得关注的是,自6月8日正式被纳入香港恒生科技指数以来,仅两个交易日,智谱累计跌幅已超过20%。
“大模型第一股”熄火?智谱股价自高点腰斩!纳入恒生科技指数两日市值再蒸发超20%
看
21
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
函盖乾坤截断众流随波逐浪
函盖乾坤截断众流随波逐浪
·
06-09
不近也不远
本轮美股牛市与历史泡沫顶峰相比还差多远?
高盛首席美股策略师Ben Snider最新报告揭示,当前市场亢奋程度已升至历史第86百分位,逼近但未及2000年互联网泡沫与2021年牛市顶峰。标普500近两个月狂飙15%,创50年来波动率调整后最强反弹纪录。四大顶峰信号尚未全面触发,但每一项都比年初更接近警戒线——窗口仍开着,却正在慢慢收窄。
本轮美股牛市与历史泡沫顶峰相比还差多远?
看
24
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
函盖乾坤截断众流随波逐浪
函盖乾坤截断众流随波逐浪
·
06-06
分析的很好,在我看来统归两句话足矣。外部市场在通胀未来需要加息,中国市场在通缩未来需要降息,而股票买的是预期。
@遵守纪律 不临时做决定:
港股科技进入左侧底部区间、短期情绪拐点落地,但中长期趋势拐点尚未完全确认(震荡磨底+结构性分化),6月初大涨是业绩+AI催化的修复行情,不是单边牛市起点。 一、已经出现的三大拐点信号(左侧底确认) 1. 估值拐点:历史低位,下行空间封死 恒生科技PE处于近10年10%~30%低分位,互联网龙头(腾讯、阿里)扣非PE仅11~15倍,大幅折价纳斯达克科技,悲观估值定价基本出清,下跌性价比远小于上涨赔率。 南向资金2026年持续逆势加仓科技龙头,5月大跌期间大额净流入,形成内资托底盘。 2. 基本面拐点:盈利见底、内卷出清 1. 本地生活盈利修复:美团Q1外卖亏损从百亿收窄至20亿,补贴大战阶段性结束,平台盈利周期开启; 2. 大厂主业稳健:腾讯Q1营收+9%、净利润+21%,阿里云、广告主业稳步回暖,传统现金业务利润企稳; 3. AI从烧钱到变现:阿里云AI收入连续11个季度三位数增长、联想AI业务收入翻倍、腾讯混元+微信AI即将落地,AI由概念逐步落地营收端。 3. 政策拐点:平台监管落地 反垄断、数据合规整改收尾,监管从强约束转为常态化,压制互联网多年的政策折价持续收敛。 二、三大未落地条件=趋势拐点还没到(仍会反复震荡) 1. 外资趋势性回流没来(港股最核心资金) 当前仅被动指数资金小幅流入,长线主动外资尚未批量进场,美联储降息落地、美债利率下行才是外资大举入场关键窗口(市场集中观望8月杰克逊霍尔会议)。 2. 指数结构短板难短期修复 恒科权重近40%是电商、本地生活等消费属性平台,硬科技(芯片、算力)占比仅12%,全球AI红利优先兑现上游硬件,平台AI商业化落地慢、兑现周期长,难复刻美股算力行情,反弹颠簸是常态。 3. 内需宏观尚未实质性回暖 平台业绩一半锚定国内消费,消费复苏偏弱压制广告、电商收入弹性,内需数据持续改善前,业绩难持续超预期走强。
港股科技进入左侧底部区间、短期情绪拐点落地,但中长期趋势拐点尚未完全确认(震荡磨底+结构性分化),6月初大涨是业绩+AI催化的修复行情,不是单边牛市起点。 一、已经出现的三大拐点信号(左侧底确认) 1. 估值拐点:历史低位,下行空间封死 恒生科技PE处于近10年10%~30%低分位,互联网龙头(腾讯、阿里)扣非PE仅11~15倍,大幅折价纳斯达克科技,悲观估值定价基本出清,下跌性价比远小于上涨赔率。 南向资金2026年持续逆势加仓科技龙头,5月大跌期间大额净流入,形成内资托底盘。 2. 基本面拐点:盈利见底、内卷出清 1. 本地生活盈利修复:美团Q1外卖亏损从百亿收窄至20亿,补贴大战阶段性结束,平台盈利周期开启; 2. 大厂主业稳健:腾讯Q1营收+9%、净利润+21%,阿里云、广告主业稳步回暖,传统现金业务利润企稳; 3. AI从烧钱到变现:阿里云AI收入连续11个季度三位数增长、联想AI业务收入翻倍、腾讯混元+微信AI即将落地,AI由概念逐步落地营收端。 3. 政策拐点:平台监管落地 反垄断、数据合规整改收尾,监管从强约束转为常态化,压制互联网多年的政策折价持续收敛。 二、三大未落地条件=趋势拐点还没到(仍会反复震荡) 1. 外资趋势性回流没来(港股最核心资金) 当前仅被动指数资金小幅流入,长线主动外资尚未批量进场,美联储降息落地、美债利率下行才是外资大举入场关键窗口(市场集中观望8月杰克逊霍尔会议)。 2. 指数结构短板难短期修复 恒科权重近40%是电商、本地生活等消费属性平台,硬科技(芯片、算力)占比仅12%,全球AI红利优先兑现上游硬件,平台AI商业化落地慢、兑现周期长,难复刻美股算力行情,反弹颠簸是常态。 3. 内需宏观尚未实质性回暖 平台业绩一半锚定国内消费,消费复苏偏弱压制广告、电商收入弹性,内需数据持续改善前,业绩难持续超预期走强。
看
214
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
函盖乾坤截断众流随波逐浪
函盖乾坤截断众流随波逐浪
·
06-06
$中芯国际(00981)$
国家集成电路产业投资基金(大基金)对中芯国际H股的多头持仓比例已降至8%以下,市场对国家队资金持续退出的担忧情绪仍在发酵
看
1,228
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
函盖乾坤截断众流随波逐浪
函盖乾坤截断众流随波逐浪
·
06-05
市场开始发癫
SpaceX IPO认购规模据悉超过供发行的股份数
超额认购是与投资者进行一对一沟通的结果。
SpaceX IPO认购规模据悉超过供发行的股份数
看
381
回复
评论
点赞
2
编组 21备份 2
分享
举报
函盖乾坤截断众流随波逐浪
函盖乾坤截断众流随波逐浪
·
05-25
[开心] [开心] [开心] [开心]
币安创始人赵长鹏在迪拜冲浪被激流卷走失踪?赵长鹏:假新闻
他澄清自己并不冲浪。
币安创始人赵长鹏在迪拜冲浪被激流卷走失踪?赵长鹏:假新闻
看
436
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
函盖乾坤截断众流随波逐浪
函盖乾坤截断众流随波逐浪
·
05-24
看来这次有望达成真正停火,之后的变数可能取决于中期选举结果。
有待最终敲定!特朗普称美伊协议基本谈成,细节将于近期公布
据悉,斡旋方巴基斯坦已促成双方接近达成临时协议。特朗普称美伊协议基本谈成,各方确认谈判“取得进展”美东时间23日下午,美国总统特朗普在社交媒体发文,称美国与伊朗已经基本谈成一份协议。特朗普称,美国与伊朗的一份协议已基本谈成,有待美伊双方及相关伊斯兰国家最终敲定。协议的最后环节与细节目前正在商讨中,将于近期公布。特朗普称,目前达成协议的可能性“大约占一半”。如果伊朗拒绝协议,将面临“负面后果”。
有待最终敲定!特朗普称美伊协议基本谈成,细节将于近期公布
看
391
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
函盖乾坤截断众流随波逐浪
函盖乾坤截断众流随波逐浪
·
05-22
这篇文章不错,转发给大家看看
@函盖乾坤截断众流随波逐浪:
$Plug Power(PLUG)$
$Plug Power(PLUG)$
看
356
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
函盖乾坤截断众流随波逐浪
函盖乾坤截断众流随波逐浪
·
05-22
绝食还能抑制癌症呢
减重神药或能抑制癌症发展,诺和诺德、礼来迎重磅利好
四项覆盖数十万患者的研究显示,Ozempic(司美格鲁肽)、Mounjaro(替尔泊肽)等明星减肥药或能抑制癌症发展——肺癌进展率近乎减半,乳腺癌五年生存率从89.5%跃升至95%以上。研究人员指出,现有证据仅显示关联性,而非因果关系。若抗癌效益最终获证,将再度重塑诺和诺德与礼来的医学与商业版图。
减重神药或能抑制癌症发展,诺和诺德、礼来迎重磅利好
看
525
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
函盖乾坤截断众流随波逐浪
函盖乾坤截断众流随波逐浪
·
05-21
$燃料电池能源(FCEL)$
太残暴了
看
840
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
暂无关注
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3544441872957647","uuid":"3544441872957647","gmtCreate":1581347850858,"gmtModify":1757109172196,"name":"函盖乾坤截断众流随波逐浪","pinyin":"hgqkjdzlsbzlhangaiqiankunjieduanzhongliusuibozhulang","introduction":"","introductionEn":"","signature":"内求,无漏","avatar":"https://static.tigerbbs.com/f4602544b3ccc4c41a2be942e28cbf75","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":304,"headSize":170,"tweetSize":877,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":7,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"ed59ff8abb2e40a58b8c1442c70110e3-3","templateUuid":"ed59ff8abb2e40a58b8c1442c70110e3","name":"2026元宝x3","description":"2026年度投资收益超越30万美金","bigImgUrl":"https://static.tigerbbs.com/f6201d4617e1ae2ee84d4a42681c4161","smallImgUrl":"https://static.tigerbbs.com/c30c473ad357518e9fa3b534ab6b31ef","grayImgUrl":null,"redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.05.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":6001,"isScarce":1,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":{"bgColor":{"dark":"#2f2a1f","tint":"#fcf6e5"},"fontColor":{"dark":"#dea95e","tint":"#885600"}},"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"99a38ff64bfd44f891fd016771fc8f64-1","templateUuid":"99a38ff64bfd44f891fd016771fc8f64","name":"超级披露者","description":"在交易分享中开启超级披露","bigImgUrl":"https://static.tigerbbs.com/802f4014829adb4e63332fc230b97e42","smallImgUrl":"https://static.tigerbbs.com/70e97d213ed3e4f4820224f1366d402f","grayImgUrl":null,"redirectLinkEnabled":1,"redirectLinkType":1,"redirectLink":"https://www.itigerup.com/activity/forapp/star-investor","redirectLinkValidityFrom":1776816000000,"redirectLinkValidityTo":2156198400000,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1104,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"1fdf9860bad64f22bc8215fc658dec98-1","templateUuid":"1fdf9860bad64f22bc8215fc658dec98","name":"2025元宝x4","description":"2025年度投资收益达成40万美金","bigImgUrl":"https://static.tigerbbs.com/59b828d482e21548a20aeeb15de7b7f8","smallImgUrl":"https://static.tigerbbs.com/59b828d482e21548a20aeeb15de7b7f8","grayImgUrl":null,"redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.01.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":6001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"d5d1b81d9a9a4306a42a1560851c3454-3","templateUuid":"d5d1b81d9a9a4306a42a1560851c3454","name":"实盘挑战","description":"累计达6个月","bigImgUrl":"https://static.tigerbbs.com/9fec469914e1280bf4801f36539f41fd","smallImgUrl":"https://static.tigerbbs.com/890d6c2bdab9dd1b255a1e7e9ae2264f","grayImgUrl":"https://static.tigerbbs.com/aeea12778e0c2c686984e1efc3ed8fd4","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":1701388800000,"redirectLinkValidityTo":1725062400000,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.08.03","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":5600,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"5697d37f217342faaa027fdb5a6e7c12-4","templateUuid":"5697d37f217342faaa027fdb5a6e7c12","name":"单笔平均盈利排行","description":"Top 10%","bigImgUrl":"https://static.tigerbbs.com/5d4a486b5707ca641782b8afa4d3261e","smallImgUrl":"https://static.tigerbbs.com/9d61ed9b62f2e13f9335a3de3bd18529","grayImgUrl":"https://static.tigerbbs.com/320fb40401f70873e9d982813fe82344","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":1691625600000,"redirectLinkValidityTo":1725062400000,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.16","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":5200,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"1f74612b6f95455f970edd02b5316db8-6","templateUuid":"1f74612b6f95455f970edd02b5316db8","name":"收益排行","description":"Top 3%","bigImgUrl":"https://static.tigerbbs.com/6fbaa8e552e02eae8e6a2ce5d6566431","smallImgUrl":"https://static.tigerbbs.com/98862e418516dab972bed7aaf561dec6","grayImgUrl":"https://static.tigerbbs.com/3a5ca933a5695ed2e862b228f6c09ee5","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":1691625600000,"redirectLinkValidityTo":1725062400000,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.10","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":5300,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"02aa7f16703b4ce4ace6f1a7665789cc-2","templateUuid":"02aa7f16703b4ce4ace6f1a7665789cc","name":"知识探索家","description":"观看学堂课程满20节","bigImgUrl":"https://static.tigerbbs.com/63cc10a4789c3eaa019b225a55136cf9","smallImgUrl":"https://static.tigerbbs.com/b1f0cbf3ae1b0a4593ddb3434df74ce0","grayImgUrl":null,"redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":2006,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.51%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.90%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":12,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":8,"crmLevelSwitch":1,"location":"河北","starInvestorFollowerNum":228,"starInvestorFlag":true,"starInvestorOrderShareNum":214,"subscribeStarInvestorNum":101,"ror":68.93,"winRationPercentage":40,"showRor":true,"investmentPhilosophy":"内求、无漏","starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":573611751274128,"gmtCreate":1781071580272,"gmtModify":1781072977465,"author":{"id":"3544441872957647","authorId":"3544441872957647","name":"函盖乾坤截断众流随波逐浪","avatar":"https://static.tigerbbs.com/f4602544b3ccc4c41a2be942e28cbf75","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3544441872957647","idStr":"3544441872957647"},"themes":[],"title":"","htmlText":"恒科成了垃圾桶","listText":"恒科成了垃圾桶","text":"恒科成了垃圾桶","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/573611751274128","repostId":"1132199346","repostType":4,"repost":{"id":"1132199346","kind":"news","pubTimestamp":1781062693,"share":"https://www.laohu8.com/m/news/1132199346?lang=zh_CN&edition=full","pubTime":"2026-06-10 11:38","market":"hk","language":"zh","title":"“大模型第一股”熄火?智谱股价自高点腰斩!纳入恒生科技指数两日市值再蒸发超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132199346","media":"sina","summary":"值得关注的是,自6月8日正式被纳入香港恒生科技指数以来,仅两个交易日,智谱累计跌幅已超过20%。","content":"<html><head></head><body><p style=\"text-align: left;\">6月10日消息,“大模型第一股 $” <a href=\"https://laohu8.com/S/02513\">智谱</a> 盘中一度跌近10%,最低触及1011港元,股价持续探底。</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/bfa23f2381bba8978bc7f3b7d7bc4447\" data-align=\"center\" tg-width=\"353\" tg-height=\"350\"/><span></span></p><p style=\"text-align: left;\">数据显示,自5月29日盘中创下1993港元的历史峰值以来,公司股价已大幅回撤,累计跌幅逼近50%,市值较高点蒸发超过4000亿港元。值得关注的是,自6月8日正式被纳入香港恒生科技指数以来,仅两个交易日,智谱累计跌幅已超过20%。</p><p style=\"text-align: left;\">此番崩跌背后,多重利空持续压制市场情绪。最大的隐忧来自即将到来的巨额解禁——智谱将于7月8日迎来首批限售股解禁,涉及约1198.59万股基石投资者股份,市场对解禁后潜在的抛售压力担忧持续升温。</p><p style=\"text-align: left;\">与股价的断崖式下跌形成鲜明对比的是,公司基本面依然深陷亏损泥潭。2025年年报显示,智谱全年实现营业收入7.24亿元,同比增长131.9%,但净亏损高达47.18亿元,亏损规模远超同期收入。按历史高点市值计算,其市销率超过千倍,估值泡沫争议不断。</p></body></html>","source":"lsy1696758196214","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>“大模型第一股”熄火?智谱股价自高点腰斩!纳入恒生科技指数两日市值再蒸发超20%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n“大模型第一股”熄火?智谱股价自高点腰斩!纳入恒生科技指数两日市值再蒸发超20%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-10 11:38 北京时间 <a href=https://finance.sina.com.cn/stock/hkstock/2026-06-10/doc-iniawttz1411297.shtml><strong>sina</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>6月10日消息,“大模型第一股 $” 智谱 盘中一度跌近10%,最低触及1011港元,股价持续探底。数据显示,自5月29日盘中创下1993港元的历史峰值以来,公司股价已大幅回撤,累计跌幅逼近50%,市值较高点蒸发超过4000亿港元。值得关注的是,自6月8日正式被纳入香港恒生科技指数以来,仅两个交易日,智谱累计跌幅已超过20%。此番崩跌背后,多重利空持续压制市场情绪。最大的隐忧来自即将到来的巨额解禁...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/2026-06-10/doc-iniawttz1411297.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://community-static.tradeup.com/news/1110d7c09edf473cbd9a975c2ede584c","relate_stocks":{"02513":"智谱"},"source_url":"https://finance.sina.com.cn/stock/hkstock/2026-06-10/doc-iniawttz1411297.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132199346","content_text":"6月10日消息,“大模型第一股 $” 智谱 盘中一度跌近10%,最低触及1011港元,股价持续探底。数据显示,自5月29日盘中创下1993港元的历史峰值以来,公司股价已大幅回撤,累计跌幅逼近50%,市值较高点蒸发超过4000亿港元。值得关注的是,自6月8日正式被纳入香港恒生科技指数以来,仅两个交易日,智谱累计跌幅已超过20%。此番崩跌背后,多重利空持续压制市场情绪。最大的隐忧来自即将到来的巨额解禁——智谱将于7月8日迎来首批限售股解禁,涉及约1198.59万股基石投资者股份,市场对解禁后潜在的抛售压力担忧持续升温。与股价的断崖式下跌形成鲜明对比的是,公司基本面依然深陷亏损泥潭。2025年年报显示,智谱全年实现营业收入7.24亿元,同比增长131.9%,但净亏损高达47.18亿元,亏损规模远超同期收入。按历史高点市值计算,其市销率超过千倍,估值泡沫争议不断。","news_type":1,"symbols_score_info":{"02513":2.1}},"isVote":1,"tweetType":1,"viewCount":21,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":573217412687064,"gmtCreate":1780980828050,"gmtModify":1780982840351,"author":{"id":"3544441872957647","authorId":"3544441872957647","name":"函盖乾坤截断众流随波逐浪","avatar":"https://static.tigerbbs.com/f4602544b3ccc4c41a2be942e28cbf75","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3544441872957647","idStr":"3544441872957647"},"themes":[],"title":"","htmlText":"不近也不远","listText":"不近也不远","text":"不近也不远","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/573217412687064","repostId":"2642459165","repostType":4,"repost":{"id":"2642459165","kind":"highlight","weMediaInfo":{"introduction":"追踪全球财经热点,精选影响您财富的资讯,投资理财必备神器!","home_visible":1,"media_name":"华尔街见闻","id":"1084101182","head_image":"https://static.tigerbbs.com/66809d1f5c2e43e2bdf15820c6d6897e"},"pubTimestamp":1780980227,"share":"https://www.laohu8.com/m/news/2642459165?lang=zh_CN&edition=full","pubTime":"2026-06-09 12:43","market":"hk","language":"zh","title":"本轮美股牛市与历史泡沫顶峰相比还差多远?","url":"https://stock-news.laohu8.com/highlight/detail?id=2642459165","media":"华尔街见闻","summary":"高盛首席美股策略师Ben Snider最新报告揭示,当前市场亢奋程度已升至历史第86百分位,逼近但未及2000年互联网泡沫与2021年牛市顶峰。标普500近两个月狂飙15%,创50年来波动率调整后最强反弹纪录。四大顶峰信号尚未全面触发,但每一项都比年初更接近警戒线——窗口仍开着,却正在慢慢收窄。","content":"<html><head></head><body><blockquote><p>高盛首席美股策略师Ben Snider最新报告揭示,当前市场亢奋程度已升至历史第86百分位,逼近但未及2000年互联网泡沫与2021年牛市顶峰。标普500近两个月狂飙15%,创50年来波动率调整后最强反弹纪录。四大顶峰信号尚未全面触发,但每一项都比年初更接近警戒线——窗口仍开着,却正在慢慢收窄。</p></blockquote><p style=\"text-align: justify;\">高盛首席美股策略师最新评估显示,当前市场亢奋程度已升至历史86百分位,正在逼近但尚未触及2000年互联网泡沫与2021年牛市顶峰时的极端水平。</p><p style=\"text-align: justify;\">近两个月内,标普500指数在周五回调前累计飙升15%,这一涨幅在1980年以来的历史数据中位居第99百分位。高盛首席美股策略师Ben Snider在其最新报告中指出,<strong>尽管投机狂热、增长恶化、股票大规模发行以及美联储收紧政策这四大历史牛市顶峰信号目前均未完全成立,但每一项都比数月前更接近触发阈值。</strong></p><p style=\"text-align: justify;\">对市场而言,这一判断意味着当前牛市尚有空间,但风险正在积累。Snider明确表示"我们还没到那一步",同时警告称,市场无需等到投资者极度亢奋才会出现下跌,历史规律不一定会在本轮周期中重演。</p><h2 id=\"id_2056469807\">涨势之猛:50年来波动率调整后最强反弹</h2><p style=\"text-align: justify;\">本轮反弹的速度之快,已在历史上留下印记。据高盛数据,标普500指数在约两个月内上涨15%,相对于已实现波动率的收益/波动率比率接近4,为逾50年来最高水平。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cbdb70068d014ba53ad14eb775d7db04\" tg-width=\"557\" tg-height=\"421\"/></p><p style=\"text-align: justify;\">人工智能是驱动本轮行情的核心主题。AI概念股、动量因子与大盘指数三者同步拉升,形成高度共振。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/84462372c92b975b14c47c4ccf71c3ff\" tg-width=\"571\" tg-height=\"413\"/></p><p style=\"text-align: justify;\">Snider指出,与此前类似的动量驱动行情(如1999年底和2021年底)不同,本轮上涨的主要支撑来自近期盈利预期的大幅上调,而非单纯的情绪泡沫,这在一定程度上赋予了本轮涨势更扎实的基本面依托。</p><h2 id=\"id_3691559974\">亢奋指标:第86百分位,低于两次历史顶峰</h2><p style=\"text-align: justify;\">为量化当前市场情绪,Snider构建了涵盖四大类别、共九项指标的综合评估框架。历史数据显示,2000年互联网泡沫顶峰时,<strong>这些指标的中位数排名达到历史第100百分位;2021年牛市高点时为第95百分位。而当前读数为第86百分位——高于历史均值,但与前两次极端顶峰仍存在明显差距。</strong></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/11c881c938c0a8db29ae85240945d38c\" tg-width=\"566\" tg-height=\"408\"/></p><p style=\"text-align: justify;\">具体来看,高盛的投机交易指标近月有所上升,但仍低于2025年底的水平,更远低于2000年和2021年的峰值。在各类投机交易活动中,高估值股票的成交量近期明显放大,而亏损股票的交易活跃度相对温和。此外,股票看涨期权成交量与散户融资余额均呈上升趋势,显示投资者情绪正在升温。</p><p style=\"text-align: justify;\">值得注意的是,本轮反弹的市场广度极为狭窄,但尚未达到互联网泡沫时期的极端集中程度。</p><h2 id=\"id_3541967083\">四大风险信号:尚未触发,但距离缩短</h2><p style=\"text-align: justify;\">高盛的分析框架将历史上高估值、高集中度牛市的终结归因于四类因素:<strong>投机狂热、增长前景恶化、股票发行量极度膨胀,以及美联储政策收紧。Snider指出,这四项条件目前均不完全符合当下环境,但每一项都比年初时更接近警戒线。</strong></p><p style=\"text-align: justify;\">IPO活动正在回暖,股票发行端的压力开始显现;投入成本上升正在压缩企业利润率,对增长前景构成潜在威胁;利率市场的定价已开始反映美联储加息的概率上升,尽管高盛经济学家认为实际加息的可能性不大。</p><p style=\"text-align: justify;\">Snider同时强调,市场下跌并不以投资者极度亢奋为前提条件,过去牛市顶峰所呈现的亢奋特征也未必会在本轮周期中以相同形式重现。这意味着,即便当前指标尚未触及历史极值,投资者也不应将其视为安全边际的充分保证。</p><p style=\"text-align: justify;\">综合来看,高盛的评估给出了一个审慎但并不悲观的判断:本轮牛市的亢奋程度正在"越来越接近"历史顶峰区间,但尚未抵达。支撑这一判断的关键在于,当前上涨仍有盈利预期改善作为基本面背书,而非纯粹由情绪驱动。然而,随着动量因子持续强势、市场集中度高企、部分风险信号悄然升温,Snider的报告实质上是在提示投资者:窗口仍然开着,但正在慢慢收窄。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>本轮美股牛市与历史泡沫顶峰相比还差多远?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n本轮美股牛市与历史泡沫顶峰相比还差多远?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1084101182\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/66809d1f5c2e43e2bdf15820c6d6897e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">华尔街见闻 </p>\n<p class=\"h-time\">2026-06-09 12:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><blockquote><p>高盛首席美股策略师Ben Snider最新报告揭示,当前市场亢奋程度已升至历史第86百分位,逼近但未及2000年互联网泡沫与2021年牛市顶峰。标普500近两个月狂飙15%,创50年来波动率调整后最强反弹纪录。四大顶峰信号尚未全面触发,但每一项都比年初更接近警戒线——窗口仍开着,却正在慢慢收窄。</p></blockquote><p style=\"text-align: justify;\">高盛首席美股策略师最新评估显示,当前市场亢奋程度已升至历史86百分位,正在逼近但尚未触及2000年互联网泡沫与2021年牛市顶峰时的极端水平。</p><p style=\"text-align: justify;\">近两个月内,标普500指数在周五回调前累计飙升15%,这一涨幅在1980年以来的历史数据中位居第99百分位。高盛首席美股策略师Ben Snider在其最新报告中指出,<strong>尽管投机狂热、增长恶化、股票大规模发行以及美联储收紧政策这四大历史牛市顶峰信号目前均未完全成立,但每一项都比数月前更接近触发阈值。</strong></p><p style=\"text-align: justify;\">对市场而言,这一判断意味着当前牛市尚有空间,但风险正在积累。Snider明确表示"我们还没到那一步",同时警告称,市场无需等到投资者极度亢奋才会出现下跌,历史规律不一定会在本轮周期中重演。</p><h2 id=\"id_2056469807\">涨势之猛:50年来波动率调整后最强反弹</h2><p style=\"text-align: justify;\">本轮反弹的速度之快,已在历史上留下印记。据高盛数据,标普500指数在约两个月内上涨15%,相对于已实现波动率的收益/波动率比率接近4,为逾50年来最高水平。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cbdb70068d014ba53ad14eb775d7db04\" tg-width=\"557\" tg-height=\"421\"/></p><p style=\"text-align: justify;\">人工智能是驱动本轮行情的核心主题。AI概念股、动量因子与大盘指数三者同步拉升,形成高度共振。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/84462372c92b975b14c47c4ccf71c3ff\" tg-width=\"571\" tg-height=\"413\"/></p><p style=\"text-align: justify;\">Snider指出,与此前类似的动量驱动行情(如1999年底和2021年底)不同,本轮上涨的主要支撑来自近期盈利预期的大幅上调,而非单纯的情绪泡沫,这在一定程度上赋予了本轮涨势更扎实的基本面依托。</p><h2 id=\"id_3691559974\">亢奋指标:第86百分位,低于两次历史顶峰</h2><p style=\"text-align: justify;\">为量化当前市场情绪,Snider构建了涵盖四大类别、共九项指标的综合评估框架。历史数据显示,2000年互联网泡沫顶峰时,<strong>这些指标的中位数排名达到历史第100百分位;2021年牛市高点时为第95百分位。而当前读数为第86百分位——高于历史均值,但与前两次极端顶峰仍存在明显差距。</strong></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/11c881c938c0a8db29ae85240945d38c\" tg-width=\"566\" tg-height=\"408\"/></p><p style=\"text-align: justify;\">具体来看,高盛的投机交易指标近月有所上升,但仍低于2025年底的水平,更远低于2000年和2021年的峰值。在各类投机交易活动中,高估值股票的成交量近期明显放大,而亏损股票的交易活跃度相对温和。此外,股票看涨期权成交量与散户融资余额均呈上升趋势,显示投资者情绪正在升温。</p><p style=\"text-align: justify;\">值得注意的是,本轮反弹的市场广度极为狭窄,但尚未达到互联网泡沫时期的极端集中程度。</p><h2 id=\"id_3541967083\">四大风险信号:尚未触发,但距离缩短</h2><p style=\"text-align: justify;\">高盛的分析框架将历史上高估值、高集中度牛市的终结归因于四类因素:<strong>投机狂热、增长前景恶化、股票发行量极度膨胀,以及美联储政策收紧。Snider指出,这四项条件目前均不完全符合当下环境,但每一项都比年初时更接近警戒线。</strong></p><p style=\"text-align: justify;\">IPO活动正在回暖,股票发行端的压力开始显现;投入成本上升正在压缩企业利润率,对增长前景构成潜在威胁;利率市场的定价已开始反映美联储加息的概率上升,尽管高盛经济学家认为实际加息的可能性不大。</p><p style=\"text-align: justify;\">Snider同时强调,市场下跌并不以投资者极度亢奋为前提条件,过去牛市顶峰所呈现的亢奋特征也未必会在本轮周期中以相同形式重现。这意味着,即便当前指标尚未触及历史极值,投资者也不应将其视为安全边际的充分保证。</p><p style=\"text-align: justify;\">综合来看,高盛的评估给出了一个审慎但并不悲观的判断:本轮牛市的亢奋程度正在"越来越接近"历史顶峰区间,但尚未抵达。支撑这一判断的关键在于,当前上涨仍有盈利预期改善作为基本面背书,而非纯粹由情绪驱动。然而,随着动量因子持续强势、市场集中度高企、部分风险信号悄然升温,Snider的报告实质上是在提示投资者:窗口仍然开着,但正在慢慢收窄。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/55eb327f580527889cf30bafa92692ae","relate_stocks":{"LU2471134523.USD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (USD) ACC","SDS":"两倍做空标普500 ETF-ProShares","LU2750360641.GBP":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (GBPHDG) INC","LU2750360997.AUD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (AUDHDG) INC","GSX":"Tradr 2X Long GS Daily ETF","GPIQ":"GOLDMAN SACHS NASDAQ 100 CORE PREMIUM INCOME ETF","SPXU":"三倍做空标普500ETF-ProShares","07522":"FI二华夏纳一百","SPDN":"Direxion Daily S&P 500 Bear 1X Shares","03455":"景顺QQQ","SMAX":"ISHARES LARGE CAP MAX BUFFER SEP ETF","UDOW":"三倍做多道指30ETF-ProShares","QQQX":"Nuveen NASDAQ 100 Dynamic Overwrite","07568":"FI二南方纳指","NAPR":"Innovator Growth-100 Power Buffer ETF - April","OEF":"标普100指数ETF-iShares","NDX":"纳斯达克100指数","03034":"南方纳指一百","QDEC":"FT Vest Nasdaq-100 Buffer ETF - December","LU0106831901.USD":"贝莱德世界金融基金A2","QMAR":"FT Vest Nasdaq-100 Buffer ETF - March","DOG":"道指ETF-ProShares做空","NJAN":"Innovator Growth-100 Power Buffer ETF - January","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","QID":"两倍做空纳斯达克指数ETF-ProShares","DDM":"2倍做多道指ETF-ProShares","NOCT":"Innovator Growth-100 Power Buffer ETF - October","SPXS":"三倍做空标普500ETF-Direxion","TQQQ":"纳指三倍做多ETF","SPYQ":"2倍做多SPY Quarterly ETF-Tradr","SPYB":"Tradr 2X Long SPY Weekly ETF","BK4533":"AQR资本管理(全球第二大对冲基金)","DXD":"两倍做空道琼30指数ETF-ProShares","NJUL":"Innovator Growth-100 Power Buffer ETF - July","TQQY":"GraniteShares YieldBOOST QQQ ETF","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","IE0004091025.USD":"BNY MELLON GLOBAL OPPORTUNITIES \"B\" (USD) ACC","MMAX":"iShares Large Cap Max Buffer Mar ETF","03086":"华夏纳指","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","QLD":"2倍做多纳斯达克100指数ETF-ProShares","SH":"做空标普500-Proshares","SDOW":"三倍做空道指30ETF-ProShares","09834":"安硕纳指一百—U","SPYM":"投资组合标普500指数ETF-SPDR","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","QQQM":"NASDAQ100指数ETF-Invesco","LU2237443895.HKD":"abrdn SICAV I - GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) ACC","BK4585":"ETF&股票定投概念","SPUU":"Direxion Daily S&P 500 Bull 2x Shares","SQQQ":"纳指三倍做空ETF","SPY":"标普500ETF","UPRO":"三倍做多标普500ETF-ProShares","IVV":"标普500ETF-iShares","BK4559":"巴菲特持仓","BK4588":"碎股","BK4550":"红杉资本持仓","LU0742534661.SGD":"Fidelity America A-SGD (hedged)","07261":"华夏两倍做多纳斯达克100","LU0868494708.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) INC","BK4552":"Archegos爆仓风波概念","DIA":"道琼斯ETF","LU1868836591.USD":"CT (LUX) I AMERICAN \"1U\"(USD) ACC","SPYI":"NEOS S&P 500 High Income ETF","07266":"南方两倍做多纳指","QQQ":"纳指100ETF","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","SPYH":"Neos S&P 500 Hedged Equity Income ETF","YSPY":"GraniteShares YieldBOOST SPY ETF","09086":"华夏纳指-U",".DJI":"道琼斯","VOO":"Vanguard标普500ETF","BK4127":"投资银行业与经纪业","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","HIBL":"Direxion Daily S&P 500 High Beta Bull 3X Shares",".IXIC":"NASDAQ Composite","02834":"安硕纳指一百",".SPX":"S&P 500 Index","PSQ":"做空纳斯达克100指数ETF-ProShares","SSO":"2倍做多标普500ETF-ProShares","SPYU":"MAX S&P 500 4X Leveraged ETN","DMAX":"ISHARES LARGE CAP MAX BUFFER DEC ETF","SPXL":"三倍做多标普500ETF-Direxion"},"source_url":"https://wallstreetcn.com/articles/3774185","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2642459165","content_text":"高盛首席美股策略师Ben Snider最新报告揭示,当前市场亢奋程度已升至历史第86百分位,逼近但未及2000年互联网泡沫与2021年牛市顶峰。标普500近两个月狂飙15%,创50年来波动率调整后最强反弹纪录。四大顶峰信号尚未全面触发,但每一项都比年初更接近警戒线——窗口仍开着,却正在慢慢收窄。高盛首席美股策略师最新评估显示,当前市场亢奋程度已升至历史86百分位,正在逼近但尚未触及2000年互联网泡沫与2021年牛市顶峰时的极端水平。近两个月内,标普500指数在周五回调前累计飙升15%,这一涨幅在1980年以来的历史数据中位居第99百分位。高盛首席美股策略师Ben Snider在其最新报告中指出,尽管投机狂热、增长恶化、股票大规模发行以及美联储收紧政策这四大历史牛市顶峰信号目前均未完全成立,但每一项都比数月前更接近触发阈值。对市场而言,这一判断意味着当前牛市尚有空间,但风险正在积累。Snider明确表示\"我们还没到那一步\",同时警告称,市场无需等到投资者极度亢奋才会出现下跌,历史规律不一定会在本轮周期中重演。涨势之猛:50年来波动率调整后最强反弹本轮反弹的速度之快,已在历史上留下印记。据高盛数据,标普500指数在约两个月内上涨15%,相对于已实现波动率的收益/波动率比率接近4,为逾50年来最高水平。人工智能是驱动本轮行情的核心主题。AI概念股、动量因子与大盘指数三者同步拉升,形成高度共振。Snider指出,与此前类似的动量驱动行情(如1999年底和2021年底)不同,本轮上涨的主要支撑来自近期盈利预期的大幅上调,而非单纯的情绪泡沫,这在一定程度上赋予了本轮涨势更扎实的基本面依托。亢奋指标:第86百分位,低于两次历史顶峰为量化当前市场情绪,Snider构建了涵盖四大类别、共九项指标的综合评估框架。历史数据显示,2000年互联网泡沫顶峰时,这些指标的中位数排名达到历史第100百分位;2021年牛市高点时为第95百分位。而当前读数为第86百分位——高于历史均值,但与前两次极端顶峰仍存在明显差距。具体来看,高盛的投机交易指标近月有所上升,但仍低于2025年底的水平,更远低于2000年和2021年的峰值。在各类投机交易活动中,高估值股票的成交量近期明显放大,而亏损股票的交易活跃度相对温和。此外,股票看涨期权成交量与散户融资余额均呈上升趋势,显示投资者情绪正在升温。值得注意的是,本轮反弹的市场广度极为狭窄,但尚未达到互联网泡沫时期的极端集中程度。四大风险信号:尚未触发,但距离缩短高盛的分析框架将历史上高估值、高集中度牛市的终结归因于四类因素:投机狂热、增长前景恶化、股票发行量极度膨胀,以及美联储政策收紧。Snider指出,这四项条件目前均不完全符合当下环境,但每一项都比年初时更接近警戒线。IPO活动正在回暖,股票发行端的压力开始显现;投入成本上升正在压缩企业利润率,对增长前景构成潜在威胁;利率市场的定价已开始反映美联储加息的概率上升,尽管高盛经济学家认为实际加息的可能性不大。Snider同时强调,市场下跌并不以投资者极度亢奋为前提条件,过去牛市顶峰所呈现的亢奋特征也未必会在本轮周期中以相同形式重现。这意味着,即便当前指标尚未触及历史极值,投资者也不应将其视为安全边际的充分保证。综合来看,高盛的评估给出了一个审慎但并不悲观的判断:本轮牛市的亢奋程度正在\"越来越接近\"历史顶峰区间,但尚未抵达。支撑这一判断的关键在于,当前上涨仍有盈利预期改善作为基本面背书,而非纯粹由情绪驱动。然而,随着动量因子持续强势、市场集中度高企、部分风险信号悄然升温,Snider的报告实质上是在提示投资者:窗口仍然开着,但正在慢慢收窄。","news_type":1,"symbols_score_info":{"QLD":0.6,"QMAR":0.6,"PSQ":0.6,"NAPR":0.6,"SPY":0.6,"SDOW":0.6,"SDS":0.6,"QQQM":0.6,"SPYM":0.6,"07261":0.6,".IXIC":2,"DDM":0.6,"DOG":0.6,"SQQQ":0.6,"09834":0.6,"NOCT":0.6,"MMAX":0.6,"SPUU":0.6,"QQQX":0.6,"QID":0.6,"QQQ":0.6,"09086":0.6,"07522":0.6,"GPIQ":0.6,"NDX":2,"OEF":0.6,"SSO":0.6,"SPYB":0.6,"SPYU":0.6,"03034":0.6,"SPYI":0.6,"GSX":0.6,"03086":0.6,"TQQQ":0.6,"SH":0.6,"UPRO":0.6,"YSPY":0.6,"DIA":0.6,"07568":0.6,"IVV":0.6,"SPXL":0.6,"SPYH":0.6,"07266":0.6,"DXD":0.6,"NJUL":0.6,"TQQY":0.6,"DMAX":0.6,"QDEC":0.6,"SPYQ":0.6,"SMAX":0.6,"SPXU":0.6,"SPDN":0.6,"UDOW":0.6,".DJI":2,"HIBL":0.6,".SPX":2,"02834":0.6,"NJAN":0.6,"VOO":0.6,"03455":0.6,"SPXS":0.6}},"isVote":1,"tweetType":1,"viewCount":24,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":572125031056024,"gmtCreate":1780701287064,"gmtModify":1780703165302,"author":{"id":"3544441872957647","authorId":"3544441872957647","name":"函盖乾坤截断众流随波逐浪","avatar":"https://static.tigerbbs.com/f4602544b3ccc4c41a2be942e28cbf75","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3544441872957647","idStr":"3544441872957647"},"themes":[],"title":"","htmlText":"分析的很好,在我看来统归两句话足矣。外部市场在通胀未来需要加息,中国市场在通缩未来需要降息,而股票买的是预期。","listText":"分析的很好,在我看来统归两句话足矣。外部市场在通胀未来需要加息,中国市场在通缩未来需要降息,而股票买的是预期。","text":"分析的很好,在我看来统归两句话足矣。外部市场在通胀未来需要加息,中国市场在通缩未来需要降息,而股票买的是预期。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/572125031056024","repostId":"571793168164904","repostType":1,"repost":{"id":571793168164904,"gmtCreate":1780622128603,"gmtModify":1780623422299,"author":{"id":"3564655882982325","authorId":"3564655882982325","name":"遵守纪律 不临时做决定","avatar":"https://static.tigerbbs.com/418bc477ee8a32483561f5b6f889f359","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3564655882982325","idStr":"3564655882982325"},"themes":[],"title":"","htmlText":"港股科技进入左侧底部区间、短期情绪拐点落地,但中长期趋势拐点尚未完全确认(震荡磨底+结构性分化),6月初大涨是业绩+AI催化的修复行情,不是单边牛市起点。 一、已经出现的三大拐点信号(左侧底确认) 1. 估值拐点:历史低位,下行空间封死 恒生科技PE处于近10年10%~30%低分位,互联网龙头(腾讯、阿里)扣非PE仅11~15倍,大幅折价纳斯达克科技,悲观估值定价基本出清,下跌性价比远小于上涨赔率。 南向资金2026年持续逆势加仓科技龙头,5月大跌期间大额净流入,形成内资托底盘。 2. 基本面拐点:盈利见底、内卷出清 1. 本地生活盈利修复:美团Q1外卖亏损从百亿收窄至20亿,补贴大战阶段性结束,平台盈利周期开启; 2. 大厂主业稳健:腾讯Q1营收+9%、净利润+21%,阿里云、广告主业稳步回暖,传统现金业务利润企稳; 3. AI从烧钱到变现:阿里云AI收入连续11个季度三位数增长、联想AI业务收入翻倍、腾讯混元+微信AI即将落地,AI由概念逐步落地营收端。 3. 政策拐点:平台监管落地 反垄断、数据合规整改收尾,监管从强约束转为常态化,压制互联网多年的政策折价持续收敛。 二、三大未落地条件=趋势拐点还没到(仍会反复震荡) 1. 外资趋势性回流没来(港股最核心资金) 当前仅被动指数资金小幅流入,长线主动外资尚未批量进场,美联储降息落地、美债利率下行才是外资大举入场关键窗口(市场集中观望8月杰克逊霍尔会议)。 2. 指数结构短板难短期修复 恒科权重近40%是电商、本地生活等消费属性平台,硬科技(芯片、算力)占比仅12%,全球AI红利优先兑现上游硬件,平台AI商业化落地慢、兑现周期长,难复刻美股算力行情,反弹颠簸是常态。 3. 内需宏观尚未实质性回暖 平台业绩一半锚定国内消费,消费复苏偏弱压制广告、电商收入弹性,内需数据持续改善前,业绩难持续超预期走强。","listText":"港股科技进入左侧底部区间、短期情绪拐点落地,但中长期趋势拐点尚未完全确认(震荡磨底+结构性分化),6月初大涨是业绩+AI催化的修复行情,不是单边牛市起点。 一、已经出现的三大拐点信号(左侧底确认) 1. 估值拐点:历史低位,下行空间封死 恒生科技PE处于近10年10%~30%低分位,互联网龙头(腾讯、阿里)扣非PE仅11~15倍,大幅折价纳斯达克科技,悲观估值定价基本出清,下跌性价比远小于上涨赔率。 南向资金2026年持续逆势加仓科技龙头,5月大跌期间大额净流入,形成内资托底盘。 2. 基本面拐点:盈利见底、内卷出清 1. 本地生活盈利修复:美团Q1外卖亏损从百亿收窄至20亿,补贴大战阶段性结束,平台盈利周期开启; 2. 大厂主业稳健:腾讯Q1营收+9%、净利润+21%,阿里云、广告主业稳步回暖,传统现金业务利润企稳; 3. AI从烧钱到变现:阿里云AI收入连续11个季度三位数增长、联想AI业务收入翻倍、腾讯混元+微信AI即将落地,AI由概念逐步落地营收端。 3. 政策拐点:平台监管落地 反垄断、数据合规整改收尾,监管从强约束转为常态化,压制互联网多年的政策折价持续收敛。 二、三大未落地条件=趋势拐点还没到(仍会反复震荡) 1. 外资趋势性回流没来(港股最核心资金) 当前仅被动指数资金小幅流入,长线主动外资尚未批量进场,美联储降息落地、美债利率下行才是外资大举入场关键窗口(市场集中观望8月杰克逊霍尔会议)。 2. 指数结构短板难短期修复 恒科权重近40%是电商、本地生活等消费属性平台,硬科技(芯片、算力)占比仅12%,全球AI红利优先兑现上游硬件,平台AI商业化落地慢、兑现周期长,难复刻美股算力行情,反弹颠簸是常态。 3. 内需宏观尚未实质性回暖 平台业绩一半锚定国内消费,消费复苏偏弱压制广告、电商收入弹性,内需数据持续改善前,业绩难持续超预期走强。","text":"港股科技进入左侧底部区间、短期情绪拐点落地,但中长期趋势拐点尚未完全确认(震荡磨底+结构性分化),6月初大涨是业绩+AI催化的修复行情,不是单边牛市起点。 一、已经出现的三大拐点信号(左侧底确认) 1. 估值拐点:历史低位,下行空间封死 恒生科技PE处于近10年10%~30%低分位,互联网龙头(腾讯、阿里)扣非PE仅11~15倍,大幅折价纳斯达克科技,悲观估值定价基本出清,下跌性价比远小于上涨赔率。 南向资金2026年持续逆势加仓科技龙头,5月大跌期间大额净流入,形成内资托底盘。 2. 基本面拐点:盈利见底、内卷出清 1. 本地生活盈利修复:美团Q1外卖亏损从百亿收窄至20亿,补贴大战阶段性结束,平台盈利周期开启; 2. 大厂主业稳健:腾讯Q1营收+9%、净利润+21%,阿里云、广告主业稳步回暖,传统现金业务利润企稳; 3. AI从烧钱到变现:阿里云AI收入连续11个季度三位数增长、联想AI业务收入翻倍、腾讯混元+微信AI即将落地,AI由概念逐步落地营收端。 3. 政策拐点:平台监管落地 反垄断、数据合规整改收尾,监管从强约束转为常态化,压制互联网多年的政策折价持续收敛。 二、三大未落地条件=趋势拐点还没到(仍会反复震荡) 1. 外资趋势性回流没来(港股最核心资金) 当前仅被动指数资金小幅流入,长线主动外资尚未批量进场,美联储降息落地、美债利率下行才是外资大举入场关键窗口(市场集中观望8月杰克逊霍尔会议)。 2. 指数结构短板难短期修复 恒科权重近40%是电商、本地生活等消费属性平台,硬科技(芯片、算力)占比仅12%,全球AI红利优先兑现上游硬件,平台AI商业化落地慢、兑现周期长,难复刻美股算力行情,反弹颠簸是常态。 3. 内需宏观尚未实质性回暖 平台业绩一半锚定国内消费,消费复苏偏弱压制广告、电商收入弹性,内需数据持续改善前,业绩难持续超预期走强。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/571793168164904","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":572027850880184,"gmtCreate":1780677564713,"gmtModify":1780679183867,"author":{"id":"3544441872957647","authorId":"3544441872957647","name":"函盖乾坤截断众流随波逐浪","avatar":"https://static.tigerbbs.com/f4602544b3ccc4c41a2be942e28cbf75","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3544441872957647","idStr":"3544441872957647"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/00981\">$中芯国际(00981)$ </a> 国家集成电路产业投资基金(大基金)对中芯国际H股的多头持仓比例已降至8%以下,市场对国家队资金持续退出的担忧情绪仍在发酵","listText":"<a href=\"https://laohu8.com/S/00981\">$中芯国际(00981)$ </a> 国家集成电路产业投资基金(大基金)对中芯国际H股的多头持仓比例已降至8%以下,市场对国家队资金持续退出的担忧情绪仍在发酵","text":"$中芯国际(00981)$ 国家集成电路产业投资基金(大基金)对中芯国际H股的多头持仓比例已降至8%以下,市场对国家队资金持续退出的担忧情绪仍在发酵","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/572027850880184","isVote":1,"tweetType":1,"viewCount":1228,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":572009112966096,"gmtCreate":1780672988449,"gmtModify":1780673495323,"author":{"id":"3544441872957647","authorId":"3544441872957647","name":"函盖乾坤截断众流随波逐浪","avatar":"https://static.tigerbbs.com/f4602544b3ccc4c41a2be942e28cbf75","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3544441872957647","idStr":"3544441872957647"},"themes":[],"title":"","htmlText":"市场开始发癫","listText":"市场开始发癫","text":"市场开始发癫","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/572009112966096","repostId":"1180660151","repostType":4,"repost":{"id":"1180660151","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据,旨在帮助投资者理解世界,做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1780670926,"share":"https://www.laohu8.com/m/news/1180660151?lang=zh_CN&edition=full","pubTime":"2026-06-05 22:48","market":"us","language":"zh","title":"SpaceX IPO认购规模据悉超过供发行的股份数","url":"https://stock-news.laohu8.com/highlight/detail?id=1180660151","media":"老虎资讯综合","summary":"超额认购是与投资者进行一对一沟通的结果。","content":"<html><head></head><body><p style=\"text-align: left;\"><span>据知情人士透露,SpaceX 的首次公开募股(IPO)认购数量已超过可供发行的股票数量。一位知情人士透露,超额认购是与投资者进行一对一沟通的结果。</span></p><p style=\"text-align: left;\"><span>SpaceX的一位代表尚未对此事作出回应。</span></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SpaceX IPO认购规模据悉超过供发行的股份数</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSpaceX IPO认购规模据悉超过供发行的股份数\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2026-06-05 22:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p style=\"text-align: left;\"><span>据知情人士透露,SpaceX 的首次公开募股(IPO)认购数量已超过可供发行的股票数量。一位知情人士透露,超额认购是与投资者进行一对一沟通的结果。</span></p><p style=\"text-align: left;\"><span>SpaceX的一位代表尚未对此事作出回应。</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://community-static.tradeup.com/news/2d4d78166826b851c33184676c8ba3c3","relate_stocks":{"SPCX":"SPAC and New Issue ETF"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180660151","content_text":"据知情人士透露,SpaceX 的首次公开募股(IPO)认购数量已超过可供发行的股票数量。一位知情人士透露,超额认购是与投资者进行一对一沟通的结果。SpaceX的一位代表尚未对此事作出回应。","news_type":1,"symbols_score_info":{"SPCX":2}},"isVote":1,"tweetType":1,"viewCount":381,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":567944777052384,"gmtCreate":1779679595553,"gmtModify":1779680604288,"author":{"id":"3544441872957647","authorId":"3544441872957647","name":"函盖乾坤截断众流随波逐浪","avatar":"https://static.tigerbbs.com/f4602544b3ccc4c41a2be942e28cbf75","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3544441872957647","idStr":"3544441872957647"},"themes":[],"title":"","htmlText":"[开心] [开心] [开心] [开心] ","listText":"[开心] [开心] [开心] [开心] ","text":"[开心] [开心] [开心] [开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/567944777052384","repostId":"1122356615","repostType":4,"repost":{"id":"1122356615","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据,旨在帮助投资者理解世界,做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1779671839,"share":"https://www.laohu8.com/m/news/1122356615?lang=zh_CN&edition=full","pubTime":"2026-05-25 09:17","language":"zh","title":"币安创始人赵长鹏在迪拜冲浪被激流卷走失踪?赵长鹏:假新闻","url":"https://stock-news.laohu8.com/highlight/detail?id=1122356615","media":"老虎资讯综合","summary":"他澄清自己并不冲浪。","content":"<html><head></head><body><p>有传闻称币安创始人赵长鹏在迪拜海滩冲浪时遭遇离岸流并失联。赵长鹏在X平台发文提醒用户警惕假新闻。他澄清自己并不冲浪,风筝冲浪是另一项运动,迪拜甚至不是冲浪目的地。</p><p>他表示Surf Abu Dhabi是世界上最大的人造冲浪场所,但他还没尝试过,那里没有激流。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/59ffbf0341391d2e4f4c602b019727db\" tg-width=\"801\" tg-height=\"855\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>币安创始人赵长鹏在迪拜冲浪被激流卷走失踪?赵长鹏:假新闻</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n币安创始人赵长鹏在迪拜冲浪被激流卷走失踪?赵长鹏:假新闻\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2026-05-25 09:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>有传闻称币安创始人赵长鹏在迪拜海滩冲浪时遭遇离岸流并失联。赵长鹏在X平台发文提醒用户警惕假新闻。他澄清自己并不冲浪,风筝冲浪是另一项运动,迪拜甚至不是冲浪目的地。</p><p>他表示Surf Abu Dhabi是世界上最大的人造冲浪场所,但他还没尝试过,那里没有激流。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/59ffbf0341391d2e4f4c602b019727db\" tg-width=\"801\" tg-height=\"855\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/cbc46df69964083b5d2a8e20b363d141","relate_stocks":{},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122356615","content_text":"有传闻称币安创始人赵长鹏在迪拜海滩冲浪时遭遇离岸流并失联。赵长鹏在X平台发文提醒用户警惕假新闻。他澄清自己并不冲浪,风筝冲浪是另一项运动,迪拜甚至不是冲浪目的地。他表示Surf Abu Dhabi是世界上最大的人造冲浪场所,但他还没尝试过,那里没有激流。","news_type":1,"symbols_score_info":{"BTCmain":2}},"isVote":1,"tweetType":1,"viewCount":436,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":567549766006120,"gmtCreate":1779583176685,"gmtModify":1779584601211,"author":{"id":"3544441872957647","authorId":"3544441872957647","name":"函盖乾坤截断众流随波逐浪","avatar":"https://static.tigerbbs.com/f4602544b3ccc4c41a2be942e28cbf75","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3544441872957647","idStr":"3544441872957647"},"themes":[],"title":"","htmlText":"看来这次有望达成真正停火,之后的变数可能取决于中期选举结果。","listText":"看来这次有望达成真正停火,之后的变数可能取决于中期选举结果。","text":"看来这次有望达成真正停火,之后的变数可能取决于中期选举结果。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/567549766006120","repostId":"1132291654","repostType":4,"repost":{"id":"1132291654","kind":"news","pubTimestamp":1779581927,"share":"https://www.laohu8.com/m/news/1132291654?lang=zh_CN&edition=full","pubTime":"2026-05-24 08:18","market":"us","language":"zh","title":"有待最终敲定!特朗普称美伊协议基本谈成,细节将于近期公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1132291654","media":"央视新闻","summary":"据悉,斡旋方巴基斯坦已促成双方接近达成临时协议。特朗普称美伊协议基本谈成,各方确认谈判“取得进展”美东时间23日下午,美国总统特朗普在社交媒体发文,称美国与伊朗已经基本谈成一份协议。特朗普称,美国与伊朗的一份协议已基本谈成,有待美伊双方及相关伊斯兰国家最终敲定。协议的最后环节与细节目前正在商讨中,将于近期公布。特朗普称,目前达成协议的可能性“大约占一半”。如果伊朗拒绝协议,将面临“负面后果”。","content":"<html><head></head><body><blockquote><p>美国总统特朗普23日宣称,美伊已“基本谈成”一份协议,最终细节将很快公布,并透露霍尔木兹海峡将随之开放。美国国务卿鲁比奥同日确认谈判“正在取得进展”。伊朗方面则表示,双方正处于一份谅解备忘录的最终敲定阶段,但强调现阶段不涉及核问题细节,仅聚焦结束战争。</p><p>据悉,斡旋方巴基斯坦已促成双方接近达成临时协议。然而,以色列担忧条款对以“非常不利”,总理内塔尼亚胡紧急召集会议商讨对策。伊朗总统指责以色列欲借战争牟利。</p></blockquote><h2 id=\"id_393206041\">特朗普称美伊协议基本谈成,各方确认谈判“取得进展”</h2><p>美东时间23日下午,美国总统特朗普在社交媒体发文,称美国与伊朗已经基本谈成一份协议。</p><p style=\"text-align: justify;\">特朗普表示,他刚刚与沙特、阿联酋、卡塔尔、土耳其、埃及、约旦、巴林领导人及巴基斯坦陆军参谋长通话,讨论伊朗问题,以及与一份“和平谅解备忘录”相关的事项。</p><p style=\"text-align: justify;\">特朗普称,<strong>美国与伊朗的一份协议已基本谈成,有待美伊双方及相关伊斯兰国家最终敲定。</strong>此外,他还与以色列总理内塔尼亚胡进行了通话。协议的最后环节与细节目前正在商讨中,将于近期公布。</p><p style=\"text-align: justify;\">特朗普还说,除协议中的诸多其他内容外,霍尔木兹海峡也将随之开放。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e6adefe8280d4a3b0ab7b745a2e8260f\" title=\"\" tg-width=\"953\" tg-height=\"596\"/></p><p style=\"text-align: justify;\">当天稍早前,特朗普在接受电话采访时表示,“情况每天都在变得越来越好”。特朗普称,他相信最终协议将能阻止伊朗获取核武器,还将确保伊朗的浓缩铀得到“令人满意的处置”,并称“我只会签署一份能让我们得到所有想要内容的协议”。</p><h2 id=\"id_409537625\">美国务卿:美伊谈判“正在取得进展”</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/20851515dbeb94f763efcebfebad39ba\" title=\"\" tg-width=\"600\" tg-height=\"400\"/></p><p style=\"text-align: justify;\">当地时间5月23日,美国国务卿鲁比奥在访问印度期间表示,美国与伊朗的谈判“正在取得进展”,并强调不允许伊朗发展核武器。</p><p style=\"text-align: justify;\">鲁比奥说,美国对于伊朗不得发展核武器的立场没有改变,伊朗必须交出其拥有的高丰度浓缩铀,且不得对穿越霍尔木兹海峡的船只收取费用。</p><p style=\"text-align: justify;\">他还表示,美国总统特朗普“始终倾向于通过外交协商手段解决问题”,美方正在朝着这一方向努力,但不排除“通过任何方式解决问题”。</p><h2 id=\"id_483997238\">伊朗:伊美正处于谅解备忘录最终敲定阶段</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f88c47610d2faf9ad5bfc76069b42ce4\" title=\"\" tg-width=\"4015\" tg-height=\"2554\"/></p><p style=\"text-align: justify;\">伊朗外交部发言人巴加埃23日表示,经过数周的对话,“伊美双方的观点正朝着更加一致的方向发展”,双方目前正处于一份谅解备忘录的最终敲定阶段。</p><p style=\"text-align: justify;\">巴加埃称,在过去的一周时间里,双方的观点与立场整体呈现出逐步接近的良好势头。他说:“接下来,我们必须拭目以待,密切观察未来三到四天内究竟会发生什么。”</p><p style=\"text-align: justify;\">巴加埃强调,伊朗以坚决且强硬的态度,成功阻止了任何损害伊朗国家利益的条款被写入文本。</p><p style=\"text-align: justify;\">巴加埃表示,现阶段谈判不涉及核问题及取消制裁的细节。他表示,鉴于目前并未就核问题展开具体对话,现阶段同样不会触及取消制裁的微观细节。但伊朗要求取消制裁的明确诉求已经写入了目前的草案文本中,这是伊朗不移的坚定立场。</p><p style=\"text-align: justify;\">巴加埃说,<strong>“现阶段,我们的所有核心焦点都集中在结束这场‘强加之战’上。”</strong></p><p style=\"text-align: justify;\">巴加埃同时强调, 霍尔木兹海峡与美国没有任何关系,这一议题纯属伊朗与海峡沿岸国家之间的内部事务。</p><p style=\"text-align: justify;\">巴加埃还表示,释放伊朗被冻结资金已被列入协议草案文本,双方在现阶段不会就核计划进行任何对话,核议题属于后续阶段才会讨论的范畴。</p><h2 id=\"id_2488739082\">巴基斯坦:美伊接近达成临时协议</h2><p style=\"text-align: justify;\">当地时间23日,据巴基斯坦官方消息人士当天表示,美国与伊朗接近达成一份旨在结束战事的临时协议。这份协议将为更广泛深入的后续谈判奠定基础。</p><p style=\"text-align: justify;\">巴基斯坦三军新闻局23日发表声明说,巴陆军参谋长穆尼尔对伊朗“短暂但成效显著的”访问圆满结束,对伊朗和美国达成谅解发挥积极作用。</p><p style=\"text-align: justify;\">声明说,穆尼尔分别会见了伊朗总统佩泽希齐扬、议长卡利巴夫、外长阿拉格齐以及内政部长莫梅尼,讨论聚焦于加快当前正在进行的磋商进程,以支持中东地区实现和平与稳定并促使伊美达成最终协议。</p><p style=\"text-align: justify;\">声明强调,会晤在积极和建设性的氛围中进行,密集协商已取得“令人鼓舞”的进展,距离伊美达成最终谅解的目标更近了一步。</p><h2 id=\"id_1793471319\">美警告伊朗拒绝协议将面临“负面后果”,伊称随时回击任何侵犯</h2><p><strong>特朗普:或于24日决定是否恢复对伊军事行动</strong></p><p style=\"text-align: justify;\">当地时间5月23日,在宣布美伊已经基本谈成一份协议的几个小时前,美国总统特朗普表示,他将于当天晚些时候与谈判团队会面,讨论伊朗方面最新提议,并可能于24日决定是否恢复军事行动。</p><p style=\"text-align: justify;\">特朗普称,目前达成协议的可能性“大约占一半”。他说,美方要么达成“一项好的协议”,要么将对伊朗采取更强硬行动。</p><p><strong>伊朗:若美重启战争 将面对更沉重打击</strong></p><p style=\"text-align: justify;\">当地时间23日,伊朗伊斯兰议会议长卡利巴夫表示,此前在巴方斡旋停火期间,美国“背信弃义”发动了海上封锁。此外,卡利巴夫表示,在这段临时停火期间,<strong>伊朗武装部队进行了重组与重整</strong>。卡利巴夫还警告美国,<strong>若美政府再次犯错重启战争,美方将面对更为沉重的打击。</strong></p><p style=\"text-align: justify;\">此外,伊朗军队当天发表声明,强调将随时准备对敌人的任何侵犯做出坚决且全方位的回击。</p><p><strong>消息人士:伊朗欲以开放霍尔木兹海峡换美国赔偿</strong></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b2301cedc039d0a4e57a16421dd07a28\" title=\"\" tg-width=\"1024\" tg-height=\"683\"/></p><p>△霍尔木兹海峡(资料图)</p><p style=\"text-align: justify;\">当地时间23日,沙特方面消息显示,伊朗已向巴基斯坦调解方提交了两份方案,提出以开放霍尔木兹海峡换取美国赔偿,并要求在签署任何协议前先就制裁和被冻结资金问题进行讨论。</p><p style=\"text-align: justify;\">据消息人士表示,巴基斯坦陆军参谋长穆尼尔已向伊朗方面转达了美方信息。美方向伊朗传递的信息包括保证“如果伊朗同意达成协议,有争议的问题可以稍后解决”。<strong>如果伊朗拒绝协议,将面临“负面后果”。</strong></p><h2 id=\"id_3457284422\">以色列担忧美伊协议对己不利,伊朗指以欲借战争牟利</h2><p><strong>担忧美伊协议对以“非常不利” 内塔尼亚胡紧急开会</strong></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e4c20df1bd50a6c28e78e0679f0e4a16\" title=\"\" tg-width=\"1280\" tg-height=\"814\"/></p><p style=\"text-align: justify;\">当地时间23日,据以色列方面消息,以总理内塔尼亚胡当晚召集执政联盟各党派领导人以及安全部门负责人开会,讨论美国与伊朗正在协商中的协议。以方担心,协议条款“对以色列非常不利”。</p><p style=\"text-align: justify;\">以色列第12频道电视台以一名不愿公开姓名的以方官员为消息源报道,美国总统特朗普的特使威特科夫正竭力劝说特朗普接受协议。以方认为威特科夫“几乎不惜一切代价也要达成协议,并向特朗普施加巨大压力,阻止战争重启”。</p><p style=\"text-align: justify;\">报道称,如果国际媒体披露的协议条款属实,那么对以色列而言则“糟糕透顶”,“很难想象特朗普会同意”。协商中的协议与内塔尼亚胡的公开言论大相径庭,与特朗普几个小时前的公开言论也背道而驰。</p><p style=\"text-align: justify;\">根据媒体披露的协议条款,伊朗将以重新开放霍尔木兹海峡为条件换取经济利益,包括美国解除海上封锁、逐步放松对伊制裁尤其是解冻部分伊朗资产等,而伊朗核计划以及浓缩铀处置将稍后一步讨论。第12频道电视台说,伊朗弹道导弹计划甚至不在谈判议程内。</p><p style=\"text-align: justify;\">不过,第12频道电视台强调,特朗普与内塔尼亚胡依旧保持密切协调,彼此没有隔阂。</p><h2 id=\"id_892836215\">伊朗总统:以色列是唯一试图通过挑起战争来谋取利益的势力</h2><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6805fd61ea61d641c3b9bcb71755b138\" title=\"\" tg-width=\"1920\" tg-height=\"1080\"/></p><p style=\"text-align: justify;\">当地时间23日,伊朗总统佩泽希齐扬在会见巴基斯坦陆军参谋长穆尼尔时表示,伊朗在实践中已经证明了自身对国际法理框架的遵守。他说:“我们仅仅是在寻求恢复我们国家和人民的合法与正当权利。然而,以往与美国人谈判的历史和经验告诫我们,必须保持最高程度的谨慎与审慎。”</p><p style=\"text-align: justify;\">佩泽希齐扬表示,美国在这场冲突中不会成为赢家,而地区国家乃至全世界都将为此承担严重损失。<strong>以色列政权是唯一试图通过挑起战争来谋取自身在地区利益的势力。</strong></p><p style=\"text-align: justify;\">巴基斯坦陆军参谋长穆尼尔表示,“以色列的利益建立在地区穆斯林的冲突与分裂之上。对于任何试图平息冲突、化解危机的人,以色列都抱有极深的敌意,它根本无意看到该地区建立稳定与安全。”</p></body></html>","source":"lsy1568181200495","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>有待最终敲定!特朗普称美伊协议基本谈成,细节将于近期公布</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n有待最终敲定!特朗普称美伊协议基本谈成,细节将于近期公布\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-24 08:18 北京时间 <a href=https://ysxw.cctv.cn/article.html?toc_style_id=feeds_default&item_id=18333442675390106864&channelId=1119><strong>央视新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美国总统特朗普23日宣称,美伊已“基本谈成”一份协议,最终细节将很快公布,并透露霍尔木兹海峡将随之开放。美国国务卿鲁比奥同日确认谈判“正在取得进展”。伊朗方面则表示,双方正处于一份谅解备忘录的最终敲定阶段,但强调现阶段不涉及核问题细节,仅聚焦结束战争。据悉,斡旋方巴基斯坦已促成双方接近达成临时协议。然而,以色列担忧条款对以“非常不利”,总理内塔尼亚胡紧急召集会议商讨对策。伊朗总统指责以色列欲借战争...</p>\n\n<a href=\"https://ysxw.cctv.cn/article.html?toc_style_id=feeds_default&item_id=18333442675390106864&channelId=1119\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f881025b5912bf2c79fdeadfb7171b47","relate_stocks":{},"source_url":"https://ysxw.cctv.cn/article.html?toc_style_id=feeds_default&item_id=18333442675390106864&channelId=1119","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132291654","content_text":"美国总统特朗普23日宣称,美伊已“基本谈成”一份协议,最终细节将很快公布,并透露霍尔木兹海峡将随之开放。美国国务卿鲁比奥同日确认谈判“正在取得进展”。伊朗方面则表示,双方正处于一份谅解备忘录的最终敲定阶段,但强调现阶段不涉及核问题细节,仅聚焦结束战争。据悉,斡旋方巴基斯坦已促成双方接近达成临时协议。然而,以色列担忧条款对以“非常不利”,总理内塔尼亚胡紧急召集会议商讨对策。伊朗总统指责以色列欲借战争牟利。特朗普称美伊协议基本谈成,各方确认谈判“取得进展”美东时间23日下午,美国总统特朗普在社交媒体发文,称美国与伊朗已经基本谈成一份协议。特朗普表示,他刚刚与沙特、阿联酋、卡塔尔、土耳其、埃及、约旦、巴林领导人及巴基斯坦陆军参谋长通话,讨论伊朗问题,以及与一份“和平谅解备忘录”相关的事项。特朗普称,美国与伊朗的一份协议已基本谈成,有待美伊双方及相关伊斯兰国家最终敲定。此外,他还与以色列总理内塔尼亚胡进行了通话。协议的最后环节与细节目前正在商讨中,将于近期公布。特朗普还说,除协议中的诸多其他内容外,霍尔木兹海峡也将随之开放。当天稍早前,特朗普在接受电话采访时表示,“情况每天都在变得越来越好”。特朗普称,他相信最终协议将能阻止伊朗获取核武器,还将确保伊朗的浓缩铀得到“令人满意的处置”,并称“我只会签署一份能让我们得到所有想要内容的协议”。美国务卿:美伊谈判“正在取得进展”当地时间5月23日,美国国务卿鲁比奥在访问印度期间表示,美国与伊朗的谈判“正在取得进展”,并强调不允许伊朗发展核武器。鲁比奥说,美国对于伊朗不得发展核武器的立场没有改变,伊朗必须交出其拥有的高丰度浓缩铀,且不得对穿越霍尔木兹海峡的船只收取费用。他还表示,美国总统特朗普“始终倾向于通过外交协商手段解决问题”,美方正在朝着这一方向努力,但不排除“通过任何方式解决问题”。伊朗:伊美正处于谅解备忘录最终敲定阶段伊朗外交部发言人巴加埃23日表示,经过数周的对话,“伊美双方的观点正朝着更加一致的方向发展”,双方目前正处于一份谅解备忘录的最终敲定阶段。巴加埃称,在过去的一周时间里,双方的观点与立场整体呈现出逐步接近的良好势头。他说:“接下来,我们必须拭目以待,密切观察未来三到四天内究竟会发生什么。”巴加埃强调,伊朗以坚决且强硬的态度,成功阻止了任何损害伊朗国家利益的条款被写入文本。巴加埃表示,现阶段谈判不涉及核问题及取消制裁的细节。他表示,鉴于目前并未就核问题展开具体对话,现阶段同样不会触及取消制裁的微观细节。但伊朗要求取消制裁的明确诉求已经写入了目前的草案文本中,这是伊朗不移的坚定立场。巴加埃说,“现阶段,我们的所有核心焦点都集中在结束这场‘强加之战’上。”巴加埃同时强调, 霍尔木兹海峡与美国没有任何关系,这一议题纯属伊朗与海峡沿岸国家之间的内部事务。巴加埃还表示,释放伊朗被冻结资金已被列入协议草案文本,双方在现阶段不会就核计划进行任何对话,核议题属于后续阶段才会讨论的范畴。巴基斯坦:美伊接近达成临时协议当地时间23日,据巴基斯坦官方消息人士当天表示,美国与伊朗接近达成一份旨在结束战事的临时协议。这份协议将为更广泛深入的后续谈判奠定基础。巴基斯坦三军新闻局23日发表声明说,巴陆军参谋长穆尼尔对伊朗“短暂但成效显著的”访问圆满结束,对伊朗和美国达成谅解发挥积极作用。声明说,穆尼尔分别会见了伊朗总统佩泽希齐扬、议长卡利巴夫、外长阿拉格齐以及内政部长莫梅尼,讨论聚焦于加快当前正在进行的磋商进程,以支持中东地区实现和平与稳定并促使伊美达成最终协议。声明强调,会晤在积极和建设性的氛围中进行,密集协商已取得“令人鼓舞”的进展,距离伊美达成最终谅解的目标更近了一步。美警告伊朗拒绝协议将面临“负面后果”,伊称随时回击任何侵犯特朗普:或于24日决定是否恢复对伊军事行动当地时间5月23日,在宣布美伊已经基本谈成一份协议的几个小时前,美国总统特朗普表示,他将于当天晚些时候与谈判团队会面,讨论伊朗方面最新提议,并可能于24日决定是否恢复军事行动。特朗普称,目前达成协议的可能性“大约占一半”。他说,美方要么达成“一项好的协议”,要么将对伊朗采取更强硬行动。伊朗:若美重启战争 将面对更沉重打击当地时间23日,伊朗伊斯兰议会议长卡利巴夫表示,此前在巴方斡旋停火期间,美国“背信弃义”发动了海上封锁。此外,卡利巴夫表示,在这段临时停火期间,伊朗武装部队进行了重组与重整。卡利巴夫还警告美国,若美政府再次犯错重启战争,美方将面对更为沉重的打击。此外,伊朗军队当天发表声明,强调将随时准备对敌人的任何侵犯做出坚决且全方位的回击。消息人士:伊朗欲以开放霍尔木兹海峡换美国赔偿△霍尔木兹海峡(资料图)当地时间23日,沙特方面消息显示,伊朗已向巴基斯坦调解方提交了两份方案,提出以开放霍尔木兹海峡换取美国赔偿,并要求在签署任何协议前先就制裁和被冻结资金问题进行讨论。据消息人士表示,巴基斯坦陆军参谋长穆尼尔已向伊朗方面转达了美方信息。美方向伊朗传递的信息包括保证“如果伊朗同意达成协议,有争议的问题可以稍后解决”。如果伊朗拒绝协议,将面临“负面后果”。以色列担忧美伊协议对己不利,伊朗指以欲借战争牟利担忧美伊协议对以“非常不利” 内塔尼亚胡紧急开会当地时间23日,据以色列方面消息,以总理内塔尼亚胡当晚召集执政联盟各党派领导人以及安全部门负责人开会,讨论美国与伊朗正在协商中的协议。以方担心,协议条款“对以色列非常不利”。以色列第12频道电视台以一名不愿公开姓名的以方官员为消息源报道,美国总统特朗普的特使威特科夫正竭力劝说特朗普接受协议。以方认为威特科夫“几乎不惜一切代价也要达成协议,并向特朗普施加巨大压力,阻止战争重启”。报道称,如果国际媒体披露的协议条款属实,那么对以色列而言则“糟糕透顶”,“很难想象特朗普会同意”。协商中的协议与内塔尼亚胡的公开言论大相径庭,与特朗普几个小时前的公开言论也背道而驰。根据媒体披露的协议条款,伊朗将以重新开放霍尔木兹海峡为条件换取经济利益,包括美国解除海上封锁、逐步放松对伊制裁尤其是解冻部分伊朗资产等,而伊朗核计划以及浓缩铀处置将稍后一步讨论。第12频道电视台说,伊朗弹道导弹计划甚至不在谈判议程内。不过,第12频道电视台强调,特朗普与内塔尼亚胡依旧保持密切协调,彼此没有隔阂。伊朗总统:以色列是唯一试图通过挑起战争来谋取利益的势力当地时间23日,伊朗总统佩泽希齐扬在会见巴基斯坦陆军参谋长穆尼尔时表示,伊朗在实践中已经证明了自身对国际法理框架的遵守。他说:“我们仅仅是在寻求恢复我们国家和人民的合法与正当权利。然而,以往与美国人谈判的历史和经验告诫我们,必须保持最高程度的谨慎与审慎。”佩泽希齐扬表示,美国在这场冲突中不会成为赢家,而地区国家乃至全世界都将为此承担严重损失。以色列政权是唯一试图通过挑起战争来谋取自身在地区利益的势力。巴基斯坦陆军参谋长穆尼尔表示,“以色列的利益建立在地区穆斯林的冲突与分裂之上。对于任何试图平息冲突、化解危机的人,以色列都抱有极深的敌意,它根本无意看到该地区建立稳定与安全。”","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":391,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":566941517227576,"gmtCreate":1779451177379,"gmtModify":1779451284553,"author":{"id":"3544441872957647","authorId":"3544441872957647","name":"函盖乾坤截断众流随波逐浪","avatar":"https://static.tigerbbs.com/f4602544b3ccc4c41a2be942e28cbf75","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3544441872957647","idStr":"3544441872957647"},"themes":[],"title":"","htmlText":"这篇文章不错,转发给大家看看","listText":"这篇文章不错,转发给大家看看","text":"这篇文章不错,转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/566941517227576","repostId":"567006359023784","repostType":1,"repost":{"id":567006359023784,"gmtCreate":1779450574586,"gmtModify":1780675791251,"author":{"id":"3544441872957647","authorId":"3544441872957647","name":"函盖乾坤截断众流随波逐浪","avatar":"https://static.tigerbbs.com/f4602544b3ccc4c41a2be942e28cbf75","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3544441872957647","idStr":"3544441872957647"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/PLUG\">$Plug Power(PLUG)$ </a>","listText":"<a href=\"https://laohu8.com/S/PLUG\">$Plug Power(PLUG)$ </a>","text":"$Plug Power(PLUG)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/567006359023784","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":356,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":566775408767744,"gmtCreate":1779407212953,"gmtModify":1779414841787,"author":{"id":"3544441872957647","authorId":"3544441872957647","name":"函盖乾坤截断众流随波逐浪","avatar":"https://static.tigerbbs.com/f4602544b3ccc4c41a2be942e28cbf75","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3544441872957647","idStr":"3544441872957647"},"themes":[],"title":"","htmlText":"绝食还能抑制癌症呢","listText":"绝食还能抑制癌症呢","text":"绝食还能抑制癌症呢","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/566775408767744","repostId":"2637336886","repostType":4,"repost":{"id":"2637336886","kind":"highlight","weMediaInfo":{"introduction":"追踪全球财经热点,精选影响您财富的资讯,投资理财必备神器!","home_visible":1,"media_name":"华尔街见闻","id":"1084101182","head_image":"https://static.tigerbbs.com/66809d1f5c2e43e2bdf15820c6d6897e"},"pubTimestamp":1779403947,"share":"https://www.laohu8.com/m/news/2637336886?lang=zh_CN&edition=full","pubTime":"2026-05-22 06:52","market":"other","language":"zh","title":"减重神药或能抑制癌症发展,诺和诺德、礼来迎重磅利好","url":"https://stock-news.laohu8.com/highlight/detail?id=2637336886","media":"华尔街见闻","summary":"四项覆盖数十万患者的研究显示,Ozempic(司美格鲁肽)、Mounjaro(替尔泊肽)等明星减肥药或能抑制癌症发展——肺癌进展率近乎减半,乳腺癌五年生存率从89.5%跃升至95%以上。研究人员指出,现有证据仅显示关联性,而非因果关系。若抗癌效益最终获证,将再度重塑诺和诺德与礼来的医学与商业版图。","content":"<html><head></head><body><blockquote><p style=\"text-align: left;\">四项覆盖数十万患者的研究显示,Ozempic(司美格鲁肽)、Mounjaro(替尔泊肽)等明星减肥药或能抑制癌症发展——肺癌进展率近乎减半,乳腺癌五年生存率从89.5%跃升至95%以上。研究人员指出,现有证据仅显示关联性,而非因果关系。若抗癌效益最终获证,将再度重塑诺和诺德与礼来的医学与商业版图。</p></blockquote><p style=\"text-align: justify;\">全球最畅销的减重与糖尿病药物或将迎来又一重大突破。</p><p style=\"text-align: justify;\">四项新研究显示,<strong>诺和诺德的Ozempic和礼来的Mounjaro等GLP-1类药物,与癌症患者更好的治疗结局之间存在关联</strong>,可能进一步扩大这类已拥有数以千万用户的药物的市场前景,并为上述两家全球市值最高的制药公司提供新的增长动力。</p><p style=\"text-align: justify;\">上述研究将于本月晚些时候在美国临床肿瘤学会(ASCO)年会上发布,涵盖逾数十万名患者的数据。</p><p style=\"text-align: justify;\">其中规模最大的研究来自克利夫兰诊所癌症研究所,追踪逾1万名早期癌症患者,结果显示GLP-1药物使用者的癌症进展风险显著低于对比组——<strong>肺癌患者疾病进展率约减半,乳腺癌患者进展率同样从20%降至10%。</strong></p><p style=\"text-align: justify;\">另有研究显示,<strong>乳腺癌GLP-1使用者的五年生存率超过95%,而非使用者为89.5%。</strong></p><p style=\"text-align: justify;\">若抗癌效益最终得到证实,将进一步巩固诺和诺德与礼来的行业地位。GLP-1药物已获批用于降低心脏病发作和中风风险,并正在测试对睡眠呼吸暂停及成瘾行为的疗效,抗癌效益将再度扩展这类药物的医学价值边界,并可能重塑其定价与报销逻辑。</p><p style=\"text-align: justify;\">然而,研究人员明确指出,<strong>现有证据仅显示关联性,而非因果关系。</strong>四项研究均为回顾性观察研究,依赖保险理赔记录和医疗数据库,尚需随机对照试验加以确认。目前,诺和诺德与礼来均未针对GLP-1药物的抗癌效果开展专项临床研究。</p><h2 style=\"text-align: left; padding-left: 10px;\"><strong>多癌种进展率大幅下降,数据信号一致</strong></h2><p style=\"text-align: justify;\">克利夫兰诊所癌症研究所的研究将逾1万名确诊早期癌症后开始使用GLP-1药物的患者,与使用其他糖尿病药物的患者进行对比,结果显示GLP-1使用者的癌症扩散风险更低。</p><p style=\"text-align: justify;\">具体数据颇为引人关注:肺癌患者中,进展为晚期的比例在GLP-1组约为10%,对比组为22%,降幅约50%;乳腺癌患者进展率分别为10%和20%;结直肠癌和肝癌亦呈现具有统计学意义的下降。</p><p style=\"text-align: justify;\">"鉴于数以百万计的美国人正在使用GLP-1类药物,我们显然迫切需要了解其潜在的抗肿瘤效果,"将在ASCO年会上发布上述研究的克利夫兰诊所住院医生Dr. Mark Orland表示。</p><p style=\"text-align: justify;\">未参与任何相关研究的Dana-Farber癌症研究所乳腺肿瘤学家Dr. Jennifer Ligibel表示,"在多种癌症中,使用这些药物的人似乎癌症复发风险更低,这一发现确实令人瞩目。"</p><h2 style=\"text-align: left; padding-left: 10px;\"><strong>乳腺癌数据:发病率与生存率双双改善</strong></h2><p style=\"text-align: justify;\">另外两项研究专门聚焦乳腺癌,从发病率和生存率两个维度考察GLP-1药物的潜在作用。</p><p style=\"text-align: justify;\">德克萨斯大学MD安德森癌症中心对逾13.7万名乳腺癌患者的分析显示,GLP-1使用者的五年生存率超过95%,而非使用者为89.5%。</p><p style=\"text-align: justify;\">宾夕法尼亚大学的研究纳入近9.5万名接受乳腺影像检查的女性,发现曾使用GLP-1药物者被诊断为乳腺癌的风险低约25%,这一差异在控制年龄、体重及其他风险因素后依然成立。</p><p style=\"text-align: justify;\">MD安德森乳腺肿瘤学家、上述生存率研究的参与者Dr. Jasmine Sukumar表示:"我们在多个数据库中都观察到了信号,这确实值得关注,因为这些研究的设计各有不同。"</p><h2 style=\"text-align: left; padding-left: 10px;\"><strong>作用机制存争议:代谢改善还是直接靶向肿瘤?</strong></h2><p style=\"text-align: justify;\">科学界目前对GLP-1药物为何可能产生抗癌效果尚无定论,主要存在两种假说。</p><p style=\"text-align: justify;\">其一,GLP-1药物通过推动减重和改善代谢健康间接降低癌症风险,而体重控制和代谢健康本身均与更低的癌症发病率独立相关。</p><p style=\"text-align: justify;\">其二,GLP-1——即这类药物所模拟的激素——的受体存在于部分肿瘤细胞表面,暗示药物可能直接作用于癌症的生物学过程本身。无论哪种机制最终得到证实,均对这类药物的长期医学与商业价值具有重要意义。</p><h2 style=\"text-align: left; padding-left: 10px;\"><strong>观察性研究局限不容忽视,确认仍需随机试验</strong></h2><p style=\"text-align: justify;\">尽管数据信号具有一致性,研究人员仍对现有研究的局限性保持审慎。</p><p style=\"text-align: justify;\">四项研究均依赖回顾性保险理赔记录和医疗数据库,存在固有偏差风险:被处方GLP-1药物的患者往往拥有更好的医疗资源获取渠道和更稳定的随访记录,这些因素本身就可能独立改善治疗结局,难以与药物效果剥离。</p><p style=\"text-align: justify;\">要确认GLP-1药物自身是否驱动了上述获益,需要通过随机对照试验——严格控制收入水平、基础健康状况及医疗资源差异的研究设计——加以验证。</p><p style=\"text-align: justify;\">目前,诺和诺德与礼来均未启动针对癌症适应症的专项研究。尽管如此,克利夫兰诊所癌症研究所副主席、相关研究的主导者Dr. Jaroslaw Maciejewski表示,横跨数十万患者的一致性数据"很难被忽视"。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>减重神药或能抑制癌症发展,诺和诺德、礼来迎重磅利好</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n减重神药或能抑制癌症发展,诺和诺德、礼来迎重磅利好\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1084101182\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/66809d1f5c2e43e2bdf15820c6d6897e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">华尔街见闻 </p>\n<p class=\"h-time\">2026-05-22 06:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><blockquote><p style=\"text-align: left;\">四项覆盖数十万患者的研究显示,Ozempic(司美格鲁肽)、Mounjaro(替尔泊肽)等明星减肥药或能抑制癌症发展——肺癌进展率近乎减半,乳腺癌五年生存率从89.5%跃升至95%以上。研究人员指出,现有证据仅显示关联性,而非因果关系。若抗癌效益最终获证,将再度重塑诺和诺德与礼来的医学与商业版图。</p></blockquote><p style=\"text-align: justify;\">全球最畅销的减重与糖尿病药物或将迎来又一重大突破。</p><p style=\"text-align: justify;\">四项新研究显示,<strong>诺和诺德的Ozempic和礼来的Mounjaro等GLP-1类药物,与癌症患者更好的治疗结局之间存在关联</strong>,可能进一步扩大这类已拥有数以千万用户的药物的市场前景,并为上述两家全球市值最高的制药公司提供新的增长动力。</p><p style=\"text-align: justify;\">上述研究将于本月晚些时候在美国临床肿瘤学会(ASCO)年会上发布,涵盖逾数十万名患者的数据。</p><p style=\"text-align: justify;\">其中规模最大的研究来自克利夫兰诊所癌症研究所,追踪逾1万名早期癌症患者,结果显示GLP-1药物使用者的癌症进展风险显著低于对比组——<strong>肺癌患者疾病进展率约减半,乳腺癌患者进展率同样从20%降至10%。</strong></p><p style=\"text-align: justify;\">另有研究显示,<strong>乳腺癌GLP-1使用者的五年生存率超过95%,而非使用者为89.5%。</strong></p><p style=\"text-align: justify;\">若抗癌效益最终得到证实,将进一步巩固诺和诺德与礼来的行业地位。GLP-1药物已获批用于降低心脏病发作和中风风险,并正在测试对睡眠呼吸暂停及成瘾行为的疗效,抗癌效益将再度扩展这类药物的医学价值边界,并可能重塑其定价与报销逻辑。</p><p style=\"text-align: justify;\">然而,研究人员明确指出,<strong>现有证据仅显示关联性,而非因果关系。</strong>四项研究均为回顾性观察研究,依赖保险理赔记录和医疗数据库,尚需随机对照试验加以确认。目前,诺和诺德与礼来均未针对GLP-1药物的抗癌效果开展专项临床研究。</p><h2 style=\"text-align: left; padding-left: 10px;\"><strong>多癌种进展率大幅下降,数据信号一致</strong></h2><p style=\"text-align: justify;\">克利夫兰诊所癌症研究所的研究将逾1万名确诊早期癌症后开始使用GLP-1药物的患者,与使用其他糖尿病药物的患者进行对比,结果显示GLP-1使用者的癌症扩散风险更低。</p><p style=\"text-align: justify;\">具体数据颇为引人关注:肺癌患者中,进展为晚期的比例在GLP-1组约为10%,对比组为22%,降幅约50%;乳腺癌患者进展率分别为10%和20%;结直肠癌和肝癌亦呈现具有统计学意义的下降。</p><p style=\"text-align: justify;\">"鉴于数以百万计的美国人正在使用GLP-1类药物,我们显然迫切需要了解其潜在的抗肿瘤效果,"将在ASCO年会上发布上述研究的克利夫兰诊所住院医生Dr. Mark Orland表示。</p><p style=\"text-align: justify;\">未参与任何相关研究的Dana-Farber癌症研究所乳腺肿瘤学家Dr. Jennifer Ligibel表示,"在多种癌症中,使用这些药物的人似乎癌症复发风险更低,这一发现确实令人瞩目。"</p><h2 style=\"text-align: left; padding-left: 10px;\"><strong>乳腺癌数据:发病率与生存率双双改善</strong></h2><p style=\"text-align: justify;\">另外两项研究专门聚焦乳腺癌,从发病率和生存率两个维度考察GLP-1药物的潜在作用。</p><p style=\"text-align: justify;\">德克萨斯大学MD安德森癌症中心对逾13.7万名乳腺癌患者的分析显示,GLP-1使用者的五年生存率超过95%,而非使用者为89.5%。</p><p style=\"text-align: justify;\">宾夕法尼亚大学的研究纳入近9.5万名接受乳腺影像检查的女性,发现曾使用GLP-1药物者被诊断为乳腺癌的风险低约25%,这一差异在控制年龄、体重及其他风险因素后依然成立。</p><p style=\"text-align: justify;\">MD安德森乳腺肿瘤学家、上述生存率研究的参与者Dr. Jasmine Sukumar表示:"我们在多个数据库中都观察到了信号,这确实值得关注,因为这些研究的设计各有不同。"</p><h2 style=\"text-align: left; padding-left: 10px;\"><strong>作用机制存争议:代谢改善还是直接靶向肿瘤?</strong></h2><p style=\"text-align: justify;\">科学界目前对GLP-1药物为何可能产生抗癌效果尚无定论,主要存在两种假说。</p><p style=\"text-align: justify;\">其一,GLP-1药物通过推动减重和改善代谢健康间接降低癌症风险,而体重控制和代谢健康本身均与更低的癌症发病率独立相关。</p><p style=\"text-align: justify;\">其二,GLP-1——即这类药物所模拟的激素——的受体存在于部分肿瘤细胞表面,暗示药物可能直接作用于癌症的生物学过程本身。无论哪种机制最终得到证实,均对这类药物的长期医学与商业价值具有重要意义。</p><h2 style=\"text-align: left; padding-left: 10px;\"><strong>观察性研究局限不容忽视,确认仍需随机试验</strong></h2><p style=\"text-align: justify;\">尽管数据信号具有一致性,研究人员仍对现有研究的局限性保持审慎。</p><p style=\"text-align: justify;\">四项研究均依赖回顾性保险理赔记录和医疗数据库,存在固有偏差风险:被处方GLP-1药物的患者往往拥有更好的医疗资源获取渠道和更稳定的随访记录,这些因素本身就可能独立改善治疗结局,难以与药物效果剥离。</p><p style=\"text-align: justify;\">要确认GLP-1药物自身是否驱动了上述获益,需要通过随机对照试验——严格控制收入水平、基础健康状况及医疗资源差异的研究设计——加以验证。</p><p style=\"text-align: justify;\">目前,诺和诺德与礼来均未启动针对癌症适应症的专项研究。尽管如此,克利夫兰诊所癌症研究所副主席、相关研究的主导者Dr. Jaroslaw Maciejewski表示,横跨数十万患者的一致性数据"很难被忽视"。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","relate_stocks":{"LU2471134879.HKD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (HKD) INC","LU2552382132.HKD":"WELLINGTON US BRAND POWER \"A\" (HKD) ACC","IE00B7KXQ091.USD":"Janus Henderson Balanced A Inc USD","LLII":"REX LLY Growth & Income ETF","LU0882574055.USD":"富达全球健康医疗A ACC","LU2471134523.USD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (USD) ACC","LU2456880835.USD":"ALLIANZ GLOBAL INCOME \"AT\" (USD) ACC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","LU2471134796.USD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (USD) INC","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","IE00BFSS7M15.SGD":"Janus Henderson Balanced A Acc SGD-H","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU0234572021.USD":"高盛美国核心股票组合Acc","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","ELIL":"2倍做多LLY ETF-Direxion","LU2750360641.GBP":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (GBPHDG) INC","LU0210536198.USD":"JPM US GROWTH \"A\" ACC","BK4007":"制药","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","LU1069344957.HKD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (HKD) INC","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","ELIS":"1倍做空LLY ETF-Direxion","LU2750360997.AUD":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (AUDHDG) INC","SG9999015945.SGD":"LionGlobal Disruptive Innovation Fund A SGD","LU2023251221.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (USD) INC","LU0354030511.USD":"ALLSPRING U.S. LARGE CAP GROWTH \"I\" (USD) ACC","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU2896262040.SGD":"JPM US GROWTH FUND \"A\" (SGD) ACC","LU0823434740.USD":"BNP PARIBAS US GROWTH \"C\" (USD) INC","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","SG9999001176.USD":"United Global Healthcare Acc USD","BK4599":"减肥药","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU2087625088.SGD":"ALLSPRING US ALL CAP GROWTH \"A\" (SGDHDG) ACC","LU1814569148.SGD":"WELLINGTON GLOBAL QUALITY GROWTH \"D\" (SGDHDG) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","SG9999014898.SGD":"United Global Quality Growth Fund Dis SGD","LU0672654240.SGD":"FTIF - Franklin US Opportunities A Acc SGD-H1","LU1868836914.USD":"CT (LUX) I AMERICAN \"3\" (USD) ACC","LU0787776722.HKD":"AB SELECT US EQUITY PORTFOLIO \"A\" (HKD) ACC","SG9999018865.SGD":"United Global Quality Growth Fd Cl Dist SGD-H","LU2089283258.USD":"安联环球可持续基金Cl AM Dis","LU1548497426.USD":"安联环球人工智能AT Acc","SG9999015952.SGD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (SGD) ACC","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LLY":"礼来","LU1323610961.USD":"UBS (LUX) EQUITY SICAV - LONG TERM THEMES (USD) \"P\" (USD) ACC","SGXZ99366536.SGD":"United Global Innovation A Acc SGD-H","LU1868836591.USD":"CT (LUX) I AMERICAN \"1U\"(USD) ACC","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","LU2756315664.SGD":"ALLIANZ INCOME AND GROWTH \"AMI\" (SGDHDG) INC","LU2168564495.EUR":"AZ ALLOCATION - TREND \"AI\" (EUR) ACC","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","SG9999014906.USD":"大华全球优质成长基金Acc USD","LU1868836757.USD":"CT (LUX) I AMERICAN FUND \"2\" (USD) ACC","LU2168564222.USD":"AZ ALLOCATION - TREND \"AAZ\" (USDHDG) ACC","LU0471298777.SGD":"Blackrock Nutrition A2 SGD-H","IE00B4JS1V06.HKD":"JANUS HENDERSON BALANCED \"A2\" (HKD) ACC","LU0471298694.HKD":"BGF NUTRITION \"A2\" (HKD) ACC","LU2168564065.EUR":"AZ ALLOCATION - TREND \"AAZ\" (EUR) ACC","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","SGXZ51526630.SGD":"大华环球创新基金A Acc SGD","SG9999018857.SGD":"United Global Quality Growth Fd Cl Acc SGD-H","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU0122379950.USD":"贝莱德世界健康科学A2","LU2168563687.JPY":"AZ ALLOCATION - TREND \"AAZ\" (JPYHDG) ACC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU2746668461.USD":"MANULIFE DYNAMIC LEADERS \"AA\" (USD) ACC","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU2271345857.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (HKD) ACC","NVOH":"Novo Nordisk A/S B Shares ADRhedged","LU0323591593.USD":"SCHRODER ISF QEP GLOBAL QUALITY \"A\" (USD) ACC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LLYX":"2倍做多LLY ETF-Defiance","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","LU2168564149.EUR":"AZ ALLOCATION - TREND \"BAZ\" (EUR) ACC","NVOX":"2倍做多NVO ETF-Defiance","LLYZ":"2倍做空LLY ETF-Defiance","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU0203202063.USD":"AB SICAV I - ALL MARKET INCOME PORTFOLIO \"A2X\" (USD) ACC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","BK4581":"高盛持仓","BK4532":"文艺复兴科技持仓","SG9999015986.USD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (USD) ACC","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","SG9999017495.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"B\" (SGD) ACC","LU2756315318.SGD":"ALLIANZ INCOME AND GROWTH \"AMG\" (SGDHDG) INC A","LU1035775433.USD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (USD) INC","LU0353189680.USD":"富国美国全盘成长基金Cl A Acc","LU2023250330.USD":"ALLIANZ INCOME AND GROWTH \"AMG\" (USD) INC","LU0203201768.USD":"AB SICAV I - ALL MARKET INCOME PORTFOLIO \"AX\" (USD) INC","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU2746668974.SGD":"MANULIFE DYNAMIC LEADERS \"AA\" (SGDHDG) ACC","BK4534":"瑞士信贷持仓","LU0158827781.USD":" ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (USD) ACC","LU1917777945.USD":"安联专题基金Cl AT Acc","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","SG9999014914.USD":"UNITED GLOBAL QUALITY GROWTH (USDHDG) INC","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","IE00BJJMRX11.SGD":"Janus Henderson Balanced A Acc SGD","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","BK4516":"特朗普概念","LU2361044949.HKD":"WELLINGTON US QUALITY GROWTH \"A\" (HKD) ACC","IE00BK4W5L77.USD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (USD) ACC","LU0079474960.USD":"联博美国增长基金A","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC","LU0882574139.USD":"富达环球消费行业基金A ACC","LU1623119135.USD":"Natixis Mirova Global Sustainable Equity R-NPF/A USD","LU2462157665.USD":"ALLIANZ GLOBAL INCOME \"A\" (USD) INC","LU2361044865.SGD":"WELLINGTON US QUALITY GROWTH \"A\" (SGDHDG) ACC","IE00BK4W5M84.HKD":"HSBC GLOBAL FUNDS ICAV US EQUITY INDEX \"HC\" (HKD) ACC","SG9999014880.SGD":"大华全球优质成长基金Acc SGD","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU0964807845.USD":"ALLIANZ INCOME & GROWTH \"A\" (USD) INC","SG9999015978.USD":"利安颠覆性创新基金A","LU1127390331.HKD":"AB SICAV I - ALL MARKET INCOME PORTFOLIO \"A\" (HKD) ACC","LU1712237335.SGD":"Natixis Mirova Global Sustainable Equity H-R-NPF/A SGD","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU2361045086.USD":"WELLINGTON US QUALITY GROWTH \"A\" (USD) ACC","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","LU0133085943.USD":"T ROWE PRICE US BLUE CHIP EQUITY \"A\" ACC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","IE00B775H168.HKD":"JANUS HENDERSON BALANCED \"A5M\" (HKD) INC","IE00BFSS8Q28.SGD":"Janus Henderson Balanced A Inc SGD-H","IE00BN29S564.USD":"JANUS HENDERSON BALANCED \"A3\" (USD) INC","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","SGXZ31699556.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"C\" (SGDHDG) ACC","LU2108987350.USD":"UBS (LUX) EQUITY SICAV GLOBAL OPPORTUNITY SUSTAINABLE (USD) \"P\" (USD) ACC","LU0058720904.USD":"联博国际健康护理基金A","LU2063271972.USD":"富兰克林创新领域基金","LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","IE0004445015.USD":"JANUS HENDERSON BALANCED \"A2\" (USD) ACC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU2213496289.HKD":"ALLIANZ INCOME AND GROWTH \"AT\" (HKD) ACC","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","LU2237443895.HKD":"abrdn SICAV I - GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) ACC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","BK4585":"ETF&股票定投概念","LU2028103732.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AMG\" (USD) INC","LU2491049909.HKD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (HKD) ACC","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC","LU0238689110.USD":"贝莱德环球动力股票基金","LU0109391861.USD":"富兰克林美国机遇基金A Acc","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","LU1629891620.HKD":"ALLIANZ INCOME AND GROWTH \"AMG2\" (H2-HKD) INC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU0256863902.USD":"ALLIANZ US EQUITY \"AT\" (USD) ACC","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","LU2461242641.AUD":"WELLINGTON US QUALITY GROWTH \"A\" (AUDHDG) ACC","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","IE0001KFT4U8.USD":"FTGF CLEARBRIDGE GLOBAL GROWTH LEADERS \"A\" (USD) INC","IE00B1XK9C88.USD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A\" (USD) ACC","LU0097036916.USD":"贝莱德美国增长A2 USD","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","LU0466842654.USD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"A\" (USD) ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","BK4588":"碎股","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU0225283273.USD":"SCHRODER ISF GLOBAL EQUITY ALPHA \"A\" (USD) ACC","IE00BKDWB100.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5H\" (SGDHDG) ACC","LU0786609619.USD":"高盛全球千禧一代股票组合Acc","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","LU2360106947.USD":"BGF NUTRITION \"A4\" (USD) INC","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","LU0385154629.USD":"贝莱德营养科学基金A2","IE0005OL40V9.USD":"JANUS HENDERSON BALANCED \"A6M\" (USD) INC","LU2111349929.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (HKD) INC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LU2602419157.SGD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"AC\" (SGD) ACC","LU0683600562.USD":"AB SELECT US EQUITY \"A\" (USD) ACC","LU1145028129.USD":"ALLIANZ INCOME AND GROWTH \"AQ\" (USD) INC","LU0006306889.USD":"SCHRODER ISF US LARGE CAP \"A\" (USD) INC AV","LU1232071149.USD":"AZ FUND 1 GLOBAL GROWTH SELECTOR \"AAZ\" (USDHDG) ACC","LU2237443465.HKD":"abrdn SICAV I - GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) INC","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","IE00BJJMRY28.SGD":"Janus Henderson Balanced A Inc SGD","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","SGXZ81514606.USD":"大华环球创新基金A Acc USD","IE00BJLML261.HKD":"HSBC GLOBAL EQUITY INDEX \"HCH\" (HKD) ACC","NVO":"诺和诺德","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","LU0316494557.USD":"FRANKLIN GLOBAL FUNDAMENTAL STRATEGIES \"A\" ACC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU2552382215.SGD":"WELLINGTON US BRAND POWER \"A\" (SGDHDG) ACC","LU0353189763.USD":"ALLSPRING US ALL CAP GROWTH FUND \"I\" (USD) ACC","LU0096364046.USD":"CT (LUX) I AMERICAN \"DU\" (USD) ACC","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","LU0094547139.USD":"abrdn SICAV I - GLOBAL SUSTAINABLE EQUITY FUND \"A\" (USD) ACC","LU0708995401.HKD":"FRANKLIN U.S. OPPORTUNITIES \"A\" (HKD) ACC","LU2471134952.CNY":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (CNYHDG) INC","LU2552382058.USD":"WELLINGTON US BRAND POWER \"A\" (USD) ACC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD"},"source_url":"https://wallstreetcn.com/articles/3772873","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2637336886","content_text":"四项覆盖数十万患者的研究显示,Ozempic(司美格鲁肽)、Mounjaro(替尔泊肽)等明星减肥药或能抑制癌症发展——肺癌进展率近乎减半,乳腺癌五年生存率从89.5%跃升至95%以上。研究人员指出,现有证据仅显示关联性,而非因果关系。若抗癌效益最终获证,将再度重塑诺和诺德与礼来的医学与商业版图。全球最畅销的减重与糖尿病药物或将迎来又一重大突破。四项新研究显示,诺和诺德的Ozempic和礼来的Mounjaro等GLP-1类药物,与癌症患者更好的治疗结局之间存在关联,可能进一步扩大这类已拥有数以千万用户的药物的市场前景,并为上述两家全球市值最高的制药公司提供新的增长动力。上述研究将于本月晚些时候在美国临床肿瘤学会(ASCO)年会上发布,涵盖逾数十万名患者的数据。其中规模最大的研究来自克利夫兰诊所癌症研究所,追踪逾1万名早期癌症患者,结果显示GLP-1药物使用者的癌症进展风险显著低于对比组——肺癌患者疾病进展率约减半,乳腺癌患者进展率同样从20%降至10%。另有研究显示,乳腺癌GLP-1使用者的五年生存率超过95%,而非使用者为89.5%。若抗癌效益最终得到证实,将进一步巩固诺和诺德与礼来的行业地位。GLP-1药物已获批用于降低心脏病发作和中风风险,并正在测试对睡眠呼吸暂停及成瘾行为的疗效,抗癌效益将再度扩展这类药物的医学价值边界,并可能重塑其定价与报销逻辑。然而,研究人员明确指出,现有证据仅显示关联性,而非因果关系。四项研究均为回顾性观察研究,依赖保险理赔记录和医疗数据库,尚需随机对照试验加以确认。目前,诺和诺德与礼来均未针对GLP-1药物的抗癌效果开展专项临床研究。多癌种进展率大幅下降,数据信号一致克利夫兰诊所癌症研究所的研究将逾1万名确诊早期癌症后开始使用GLP-1药物的患者,与使用其他糖尿病药物的患者进行对比,结果显示GLP-1使用者的癌症扩散风险更低。具体数据颇为引人关注:肺癌患者中,进展为晚期的比例在GLP-1组约为10%,对比组为22%,降幅约50%;乳腺癌患者进展率分别为10%和20%;结直肠癌和肝癌亦呈现具有统计学意义的下降。\"鉴于数以百万计的美国人正在使用GLP-1类药物,我们显然迫切需要了解其潜在的抗肿瘤效果,\"将在ASCO年会上发布上述研究的克利夫兰诊所住院医生Dr. Mark Orland表示。未参与任何相关研究的Dana-Farber癌症研究所乳腺肿瘤学家Dr. Jennifer Ligibel表示,\"在多种癌症中,使用这些药物的人似乎癌症复发风险更低,这一发现确实令人瞩目。\"乳腺癌数据:发病率与生存率双双改善另外两项研究专门聚焦乳腺癌,从发病率和生存率两个维度考察GLP-1药物的潜在作用。德克萨斯大学MD安德森癌症中心对逾13.7万名乳腺癌患者的分析显示,GLP-1使用者的五年生存率超过95%,而非使用者为89.5%。宾夕法尼亚大学的研究纳入近9.5万名接受乳腺影像检查的女性,发现曾使用GLP-1药物者被诊断为乳腺癌的风险低约25%,这一差异在控制年龄、体重及其他风险因素后依然成立。MD安德森乳腺肿瘤学家、上述生存率研究的参与者Dr. Jasmine Sukumar表示:\"我们在多个数据库中都观察到了信号,这确实值得关注,因为这些研究的设计各有不同。\"作用机制存争议:代谢改善还是直接靶向肿瘤?科学界目前对GLP-1药物为何可能产生抗癌效果尚无定论,主要存在两种假说。其一,GLP-1药物通过推动减重和改善代谢健康间接降低癌症风险,而体重控制和代谢健康本身均与更低的癌症发病率独立相关。其二,GLP-1——即这类药物所模拟的激素——的受体存在于部分肿瘤细胞表面,暗示药物可能直接作用于癌症的生物学过程本身。无论哪种机制最终得到证实,均对这类药物的长期医学与商业价值具有重要意义。观察性研究局限不容忽视,确认仍需随机试验尽管数据信号具有一致性,研究人员仍对现有研究的局限性保持审慎。四项研究均依赖回顾性保险理赔记录和医疗数据库,存在固有偏差风险:被处方GLP-1药物的患者往往拥有更好的医疗资源获取渠道和更稳定的随访记录,这些因素本身就可能独立改善治疗结局,难以与药物效果剥离。要确认GLP-1药物自身是否驱动了上述获益,需要通过随机对照试验——严格控制收入水平、基础健康状况及医疗资源差异的研究设计——加以验证。目前,诺和诺德与礼来均未启动针对癌症适应症的专项研究。尽管如此,克利夫兰诊所癌症研究所副主席、相关研究的主导者Dr. Jaroslaw Maciejewski表示,横跨数十万患者的一致性数据\"很难被忽视\"。","news_type":1,"symbols_score_info":{"NVOH":0.6,"LLY":1.93,"NVOX":0.6,"LLYX":0.6,"ELIS":0.6,"LLYZ":0.6,"LLII":0.6,"ELIL":0.6,"NVO":1.94}},"isVote":1,"tweetType":1,"viewCount":525,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":566339284202280,"gmtCreate":1779300739250,"gmtModify":1779300741212,"author":{"id":"3544441872957647","authorId":"3544441872957647","name":"函盖乾坤截断众流随波逐浪","avatar":"https://static.tigerbbs.com/f4602544b3ccc4c41a2be942e28cbf75","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3544441872957647","idStr":"3544441872957647"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/FCEL\">$燃料电池能源(FCEL)$ </a><v-v data-views=\"1\"></v-v> 太残暴了","listText":"<a href=\"https://laohu8.com/S/FCEL\">$燃料电池能源(FCEL)$ </a><v-v data-views=\"1\"></v-v> 太残暴了","text":"$燃料电池能源(FCEL)$ 太残暴了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/566339284202280","isVote":1,"tweetType":1,"viewCount":840,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"following","isTTM":false}